Abengoa, S.A. Class B Shares in the form of Shares or American Depositary Shares Underwriting Agreement
Exhibit 1.1
Abengoa, S.A.
Class B Shares
in the form of Shares or American Depositary Shares
Underwriting Agreement
[·], 2013
Citigroup Global Markets Limited
Citigroup Centre
Canada Square
Xxxxxx Xxxxx, Xxxxxx X00 0XX
[·]
As Representatives of the several Underwriters
Ladies and Gentlemen:
Abengoa, S.A., a corporation organized under the laws of the Kingdom of Spain (“Spain”) (the “Company”), proposes to issue and sell to the several Underwriters, for whom you (the “Representatives”) are acting as representatives, [·] Class B shares, €0.01 par value each (such class of shares, the “Class B Shares”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Shares”). The Company also proposes to sell up to [·] additional Class B Shares to the Underwriters to cover over-allotments, if any (the “Option Shares” and together with the Underwritten Shares, the “Offered Shares”), in accordance with Section 2 hereof.
The Representatives have also advised the Company that the Underwriters may elect to cause the Company to deposit on their behalf all or any portion of the Offered Shares to be purchased by them hereunder pursuant to the Deposit Agreement, dated as of [·], 2013 (the “Deposit Agreement”), to be entered into among the Company, Citibank, N.A., as depositary (the “Depositary”) and all holders from time to time of the ADSs (as hereinafter defined). Upon deposit of any Class B Shares, the Depositary will issue American Depositary Shares (the “ADSs”) representing the Class B Shares so deposited. The ADSs will be evidenced by American Depositary Receipts (the “ADRs”). Each ADS will represent [·] Class B Shares and each ADR may represent any number of ADSs. Unless the context otherwise requires, the terms “Underwritten Shares,” “Option Shares” and “Offered Shares,” shall be deemed to refer, respectively, to Underwritten Shares, Option Shares and Offered Shares as well as, in each case, to any ADSs representing such securities and the ADRs evidencing such ADSs.
To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used in this Underwriting Agreement shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. The use of the neuter in this Underwriting Agreement shall include the feminine and masculine wherever appropriate. Certain terms used in this Underwriting Agreement are defined in Section 23 hereof.
1. Representations and Warranties. The Company represents and warrants to, and agrees with, each Underwriter as set forth below in this Section 1.
(a) The Company has prepared and filed with the Commission the Registration Statement (as hereinafter defined), including related preliminary prospectuses, for registration under the Act of the offering and sale of the Securities (as hereinafter defined) being offered in the United States. Such Registration Statement, including any amendments thereto filed prior to the Execution Time, has become effective. The Company may have filed one or more amendments thereto, including the related preliminary prospectuses, each of which has previously been furnished to you. The Company will file with the Commission a final prospectus in accordance with Rule 424(b). As filed, such final prospectus shall contain all information required by the Act and the rules thereunder and, except to the extent the Representatives shall agree in writing to a modification, shall be in all substantive respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other changes (beyond that contained in the latest Preliminary Prospectus (as hereinafter defined)) as the Company has advised you, prior to the Execution Time, will be included or made therein.
It is understood that two forms of prospectuses are to be used in connection with the offering and sale of the Offered Shares: the Prospectus relating to the offering and sale of the Securities in the United States and outside the United States (other than in Canada) and a prospectus relating to the offering and sale of the Securities in Canada (the “Canadian Prospectus”). The Prospectus and the Canadian Prospectus contain substantially identical information except for certain substitute or additional pages. Unless the context otherwise requires, references herein to the “Prospectus” whether in preliminary or final form and whether as amended or supplemented, shall include the two versions thereof referred to in this paragraph.
(b) The Company has prepared and filed with the CNMV on July 12, 2012 a registration document (documento de registro) (the “Documento de Registro”) pursuant to Annexes I and II of Commission Regulation (EC) No. 809/2004, in the Spanish language for approval and registration under the Spanish Act (as hereinafter defined). Such Documento de Registro was approved and registered by the CNMV on its official files on July 12, 2012 (file number 2012/10,185) and has not been supplemented thereafter. In addition, the Company filed a relevant fact notice (comunicación de hecho relevante) concerning the Securities (the “Relevant Fact Notice”) with the CNMV on [·], 2013, which was registered by the CNMV on its official files under file number [·]. The Company will prepare and file with the CNMV on [·] a securities note (nota sobre las acciones), in the Spanish language, pursuant to Annex III of Commission Regulation (EC) No. 809/2004 (the “Nota sobre las Acciones”), including a summary note (resumen) that, together with the Documento de Registro, will constitute the
informative prospectus (folleto informativo) (the “Folleto”) required to be filed and registered by the Company with the CNMV in connection with its application for admission to listing of the Offered Shares on the Madrid and Barcelona Stock Exchanges for trading through the SIB (as hereinafter defined). The Relevant Fact Notice and the Folleto are hereto referred to as the “Spanish Documents.”
(c) On the Effective Date, the Registration Statement did, and when the Prospectus is first filed in accordance with Rule 424(b) and on the Closing Date (as defined in Section 3(a) of this Underwriting Agreement) and on the Option Closing Date (as defined in Section 2(b) of this Underwriting Agreement), if any, the Prospectus (and any supplement thereto) will, comply in all material respects with the applicable requirements of the Act and the rules thereunder; on the Effective Date and at the Execution Time, the Registration Statement did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on the date of any filing pursuant to Rule 424(b) and on the Closing Date and on the Option Closing Date, if any, the Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no representations or warranties as to the information contained in or omitted from the Registration Statement, or the Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion in the Registration Statement or the Prospectus (or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(d) The Spanish Documents as of their dates and as of the date hereof comply, and the Spanish Documents as amended or supplemented, if applicable, as of the date of such amendment or supplement, will comply as to form and substance with Directive 2003/71/EC, as amended (the “Prospectus Directive”), the relevant implementing measures in Spain (including the Spanish Act and Royal Decree 1310/2005) and all other applicable rules and regulations (including Commission Regulation (EC) No. 809/2004). The Spanish Documents, as of their dates and as of the Execution Time, did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on the date of any amendment or supplement and on the Closing Date, the Settlement Date and the Option Closing Date, if any, the Folleto (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no representations or warranties as to the information contained in or omitted from the Folleto (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion in the Folleto, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
There is no difference in any material respect between the information contained in the Folleto and the information contained in the Registration Statement as of the Closing Date and the Option Closing Date, if any (in each case, as amended or supplemented prior thereto). The Company has provided the CNMV with all relevant documents and information required by Spanish laws and regulations or by such authorities in connection therewith.
(e) (i) The Disclosure Package and the price to the public, the number of Underwritten Shares and the number of Option Shares to be included on the cover page of the Prospectus, when taken together as a whole, and (ii) each electronic road show when taken together as a whole with the Disclosure Package and the price to the public, the number of Underwritten Shares and the number of Option Shares to be included on the cover page of the Prospectus, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package based upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(f) (i) At the time of filing the Registration Statement and (ii) as of the Execution Time (with such date being used as the determination date for purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an Ineligible Issuer.
(g) Each Issuer Free Writing Prospectus does not include any information that conflicts with the information contained in the Registration Statement, including any document incorporated by reference therein that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(h) (i) The Offered Shares to be issued and sold by the Company to the Underwriters hereunder have been duly and validly authorized and, when issued and delivered against payment therefor as provided herein, and when the capital increase relating to the Offered Shares has been duly registered with the Registro Mercantil xx Xxxxxxx (the “Mercantile Registry”) and the Offered Shares have been duly registered with Iberclear, the Offered Shares will be duly and validly issued and fully paid and non-assessable and will conform in all material respects to the description of the capital stock contained in the Disclosure Package, the Prospectus and the Nota sobre las Acciones; (ii) the Offered Shares will, when issued, be free and clear of any security interest, mortgage, pledge, lien, charge, claim, equity or encumbrance of any kind; and upon delivery of the Offered Shares and payment of the Purchase Price (as defined herein), each of the Underwriters will receive good and marketable title to the Offered Shares to be sold by it, free and clear of any security
interest, mortgage, pledge, lien, charge, claim, equity or encumbrance of any kind; (iii) no statute, rule, regulation or order has been enacted, adopted or issued by any governmental or regulatory authority in Spain or the European Union (or, so far as the Company is aware, by any other governmental or regulatory authority) that would, as of the Closing Date or the Option Closing Date, if any, prevent the issuance or sale of the Offered Shares in the manner contemplated by the Disclosure Package, the Prospectus, the Nota sobre las Acciones and this Underwriting Agreement; and (iv) no injunction or order of any national, provincial, foreign or other court has been issued and, so far as the Company is aware, no action has been taken by any governmental or regulatory authority, that would, as of the Closing Date or the Option Closing Date, if any, prevent the issuance or sale of the Offered Shares in the manner contemplated by the Disclosure Package, the Prospectus, the Nota sobre las Acciones and this Underwriting Agreement.
(i) The Company has filed with the Commission a registration statement (file number 333-[·]) on Form F-6 for the registration under the Act of the offering and sale of the ADSs. The Company may have filed one or more amendments thereto, each of which has previously been furnished to you. Such ADR Registration Statement (as hereinafter defined), including any amendments thereto filed prior to the Execution Time, has become effective, and at the time of its effectiveness did comply and on the Closing Date and the Option Closing Date, if any, will comply, in all material respects with the applicable requirements of the Act and the rules thereunder and at the time of its Effective Date and at the Execution Time, did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading.
(j) Upon issuance by the Depositary of ADSs evidenced by ADRs against deposit of Class B Shares in accordance with the provisions of the Deposit Agreement, such ADRs will be duly and validly issued and persons in whose names the ADRs are registered will be entitled to the rights specified in the ADRs and in the Deposit Agreement; the Class B Shares may be freely deposited by the Company or other holders thereof with the Depositary against issuance of ADRs evidencing the ADSs.
(k) The Offered Shares and ADSs are freely transferable by the Company to or for the account of the several Underwriters in the manner contemplated herein; and there are no restrictions on subsequent transfers of the Offered Shares or the ADSs.
(l) No stamp or other issuance or transfer taxes or duties are payable by or on behalf of any Underwriter in connection with (i) the execution and delivery of this Underwriting Agreement, (ii) the issuance by the Company or sale by the Company of the Offered Shares, (iii) the delivery of the Offered Shares in the manner contemplated by this Underwriting Agreement, (iv) the deposit with the Depositary of the Underlying Shares against issuance of the ADRs evidencing the ADSs, (v) the sale and delivery by each such Underwriter of the Offered Shares, including in the form of ADSs, as contemplated herein, or (vi) the transactions contemplated by the Stock Loan Agreement (as defined herein).
(m) Each of the Company and the subsidiaries specified in Schedule III hereto (the “Specified Subsidiaries”) has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction in which it is chartered or
organized with full corporate power and authority to own or lease, as the case may be, and to operate its properties and conduct its business as described in the Disclosure Package, the Prospectus and the Folleto (exclusive of any amendment or supplement thereto) and is duly qualified to do business as a foreign corporation and is in good standing under the laws of each jurisdiction which requires such qualification, except where the failure to be so qualified or in good standing would not have a Material Adverse Effect (as hereinafter defined).
(n) All the outstanding shares of capital stock of each subsidiary of the Company have been duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), all outstanding shares of capital stock of the subsidiaries of the Company are owned by the Company either directly or through wholly owned subsidiaries free and clear of any perfected security interest or any other security interests, claims, liens or encumbrances.
(o) There is no franchise, contract or other document of a character required to be described in the Registration Statement, ADR Registration Statement, Disclosure Package, Prospectus or the Spanish Documents, or to be filed as an exhibit to any of them, which is not described or filed as required (and each Preliminary Prospectus contains in all material respects the same description of the foregoing matters contained in the Prospectus); and the statements in each Preliminary Prospectus and the Prospectus under the headings “Taxation,” “Risk Factors—Risks Related to Our Business and the Markets in Which We Operate—Unauthorized use of our proprietary technology by third parties may reduce the value of our products, services and brand, and impair our ability to compete effectively,” “Risk Factors—Risks Related to Our Business and the Markets in Which We Operate—Our business may suffer if we are sued for infringing the intellectual property rights of third parties,” “Business—Intellectual Property,” “Business—Information Technology,” “Business—Legal Proceedings,” “Regulation,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Corporate Debt,” “Description of Share Capital,” “Description of the Share Lending Arrangements” and “Description of American Depositary Shares,” in the Documento de Registro (as of its date) in Sections 2, 5.2, 6, 8, 10, 11, 19, 20, 21 and 22, and in the Nota sobre las Acciones (as of its date) in Sections 3, 4, 5, 6, 7.3, 10, 11.1 and 11.3, in each case insofar as such statements summarize legal matters, agreements, documents or proceedings discussed therein, are accurate and fair summaries of such legal matters, agreements, documents or proceedings.
(p) The Company has full right, power and authority to execute and deliver this Underwriting Agreement and the Deposit Agreement and to perform its respective obligations hereunder and thereunder; and all action required to be taken for the due and proper authorization, execution and delivery of each of the Underwriting Agreement and the Deposit Agreement and the consummation of the transactions contemplated thereby (except, with respect to the consummation of the transactions contemplated in this Underwriting Agreement, as expressely set forth herein), as the case may be, has been duly and validly taken.
(q) The authorized, issued and outstanding share capital of the Company is as set forth in each Preliminary Prospectus and the Prospectus under the caption “Capitalization”
and in Section 3.2 of the Nota sobre las Acciones; and the Class B Shares and the ADSs conform in all material respects to the descriptions thereof contained in each Preliminary Prospectus, the Disclosure Package, the Prospectus and the Nota sobre las Acciones.
(r) (i) The issued and outstanding share capital of the Company has been duly and validly authorized, and has been issued and fully paid and is not subject to any call for the payment of further capital; (ii) none of the issued and outstanding share capital of the Company was issued in violation of any pre-emptive or other similar rights of any security holder of the Company; and (iii) except as disclosed in the Disclosure Package, the Prospectus and the Spanish Documents: (A) there are no outstanding securities convertible into or exchangeable for, or warrants, rights or options, or agreements to grant warrants, rights (including, without limitation, pre-emption rights) or options, to purchase or to subscribe for, or obligations or commitments of the Company to create, issue, sell or otherwise dispose of, any securities (or any such convertible or exchangeable securities, warrants, rights, options, obligations or commitments) of the Company; (B) there are no restrictions on the free transferability of the Offered Shares set out in the constitutional documents of the Company or under Spanish law or regulation; and (C) there are no restrictions on subsequent transfers of the Offered Shares.
(s) The statements of fact included in each road show presentation of the Company in connection with the offering and sale of the Offered Shares are consistent in all material respects with the Disclosure Package and the Prospectus, true and accurate in all material respects and are not misleading in any material respect.
(t) The Company has not entered into any contractual arrangement relating to the offer, sale, distribution or delivery of any Class B Shares or ADSs other than the Underwriting Agreement and the Deposit Agreement and the other arrangements described in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(u) The Class B Shares of the Company currently in issue are duly listed on the Madrid and Barcelona Stock Exchanges and are freely tradable in Spain and the Company is in compliance with all listing and admission requirements or continuing obligations of the Madrid and Barcelona Stock Exchanges and the CNMV and the Company will comply with all applicable requirements of The NASDAQ Stock Market in connection with the listing of the Offered Shares on the Nasdaq Global Select Market.
(v) The Company has applied to have the ADSs listed on the Nasdaq Global Select Market under the symbol “ABGB.” The ADSs have been approved for listing on the Nasdaq Global Select Market, subject to official notice for issuance.
(w) No consent, approval, authorization, filing with or order of any court or governmental agency or body is required in connection with the transactions contemplated herein, in the Deposit Agreement or in the Stock Loan Agreement, except (i) such as have been obtained under the Act and the Spanish Capital Companies Act, (ii) such as may be required under the blue sky laws of any jurisdiction in connection with the purchase and distribution of the Offered Shares by the Underwriters in the manner contemplated herein and
in the Disclosure Package, the Prospectus and the Spanish Documents, (iii) the registration of the Nota sobre las Acciones and complementary documentation with the CNMV, (iv) the formalization of the capital increase by means of a public deed granted before a Spanish notary public, the filing thereof with the competent Spanish tax authorities as tax-exempt from capital tax (Impuesto sobre Transmisiones Patrimoniales y Actos Jurídicos Documentados en su modalidad de Operaciones Societarias) and the registration of such public deed with the Mercantile Registry, (v) the registration of the Offered Shares with the Spanish securities clearing and settlement system, Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A.U. (“Iberclear”), and the verification of the listing of the Offered Shares by the CNMV, (vi) the approval of the admission to listing of the Offered Shares by the relevant managing entities (Sociedades Rectoras) of each of the Madrid and Barcelona Stock Exchanges, and (vii) the approval of the admission of the Offered Shares to trading through the SIB by the CNMV.
(x) None of the issue and sale of the Offered Shares, the consummation of any other of the transactions herein contemplated and the execution, delivery or fulfillment of the terms of the Underwriting Agreement, the Deposit Agreement or the Stock Loan Agreement will conflict with, result in a breach or violation of, or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, (i) the charter or by-laws of the Company or any of its subsidiaries, (ii) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which the Company or any of its subsidiaries is a party or bound or to which its or their property is subject, or (iii) any statute, law, rule, regulation, judgment, order or decree applicable to the Company or any of its subsidiaries of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or any of its subsidiaries or any of its or their properties, except, in the case of (ii), for such breaches, violations, liens, charges or encumbrances that would not reasonably be expected to have a Material Adverse Effect and that would also not reasonably be expected to have a material adverse effect on the ability of the Underwriters to consummate the transactions contemplated by this Underwriting Agreement.
(y) No holders of securities of the Company have rights to the registration of such securities under the Registration Statement, the ADR Registration Statement and the Spanish Documents.
(z) The consolidated historical financial statements and the related notes of the Company and its consolidated subsidiaries included in the Disclosure Package, the Prospectus, the Registration Statement and the Folleto present fairly the financial condition, results of operations and cash flows of the Company as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements of the Act and have been prepared in accordance with IFRS as issued by the IASB (as such terms are defined herein), in the case of the Disclosure Package, the Prospectus and the Registration Statement, and IFRS as adopted by the European Union, in the case of the Folleto, in each case applied on a consistent basis throughout the periods involved. The selected financial data set forth under the captions “Summary Consolidated Financial Information” and “Selected Consolidated Financial Information” in each Preliminary Prospectus and the Prospectus and in Section 3 of the Documento de Registro and Section 11.2 of the Nota sobre las Acciones fairly present, on
the basis stated in each Preliminary Prospectus, the Prospectus and the Folleto, the information included therein. The interim financial data set forth under the caption “Recent Developments” in the Disclosure Package and the Prospectus and in Section 11.3 of the Nota sobre las Acciones, was prepared in accordance with IFRS as issued by the IASB, applied on a consistent basis as the consolidated historical financial statements and the related notes of the Company and its consolidated subsidiaries included in the Disclosure Package, the Prospectus, the Registration Statement and the Folleto, as applicable. The selected financial data and any other historical financial data regarding the Company and its subsidiaries included in the Disclosure Package, the Prospectus, the Registration Statement and the Spanish Documents have been correctly extracted, derived or recalculated from, and have been compiled on a basis consistent with, the audited consolidated financial statements of the Company or the accounting records of the Company. The pro forma financial statements included in the Disclosure Package, the Prospectus, the Registration Statement and the Nota sobre las Acciones present fairly the information shown therein and include assumptions that provide a reasonable basis for presenting the significant effects directly attributable to the transactions and events described therein, the related pro forma adjustments give appropriate effect to those assumptions, and the pro forma adjustments reflect the proper application of those adjustments to the historical financial statement amounts in the pro forma financial statements included in the Disclosure Package, the Prospectus, the Registration Statement and the Nota sobre las Acciones. The pro forma financial statements included in the Disclosure Package, the Prospectus and the Registration Statement comply as to form in all material respects with the applicable accounting requirements of Regulation S-X under the Act. The pro forma financial statements and the related notes thereto and the other pro forma and as-adjusted information included in the Nota sobre las Acciones have been prepared in accordance with the disclosure rules and guidelines of Annex II of Commission Regulation (EC) No. 809/2004 and have been properly compiled on the bases described therein.
(aa) The targets set forth in each Preliminary Prospectus and the Prospectus under the caption “Business—Certain Financial Targets” [and in the Nota sobre las Acciones in Section [·] under the heading [·]], respectively, have been calculated after due, careful and proper inquiry and consideration by the Company, and represent reasonable and fair expectations honestly held by the Company based on all relevant material information known to the Company as of the date of their use. All assumptions on which such targets are based are reasonable.
(bb) The statements set forth in each Preliminary Prospectus and the Prospectus under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” and in the Nota sobre las Acciones in Section [3.1] under the heading “Declaración del capital de explotación,” respectively, accurately and fully describe all material trends, demands, commitments and events that the Company believes would materially affect liquidity and are reasonably likely to occur. The Company is not aware of any circumstances now existing or likely to arise that are likely to cause the Company not to have adequate working capital to finance its operations and the operations of its consolidated subsidiaries, in each case for a period of 12 months from the Effective Date. Taking into account the existing cash resources and other facilities available to the Company (and disregarding the proceeds from the issuance and sale of the Securities), the
Company believes that the working capital available to the Company is sufficient for its present requirements and for at least the 12 months following the Effective Date. The cash flow and working capital projections on which the Company has based its statement regarding the sufficiency of its working capital have been properly prepared after due and careful enquiry and take into account all relevant material information concerning the Company. All assumptions on which such projections are based are reasonable, and there are no other material assumptions that should reasonably be taken into account in the preparation of such projections.
(cc) Since the date of the most recent financial statements included in the Disclosure Package, the Prospectus, the Registration Statement and the Spanish Documents (exclusive of any amendment or supplement thereto), there has been no material adverse effect on the condition (financial or otherwise), prospects, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business (a “Material Adverse Effect”), except as set forth in or contemplated in the Disclosure Package, the Prospectus, the Registration Statement and the Folleto (exclusive of any amendment or supplement thereto).
(dd) No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries or its or their property is pending or, to the best knowledge of the Company, threatened that (i) could reasonably be expected to have a material adverse effect on the performance of this Underwriting Agreement or the consummation of any of the transactions contemplated hereby or (ii) could reasonably be expected to have a Material Adverse Effect, except as set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(ee) Except as otherwise set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), each of the Company and each of its subsidiaries lawfully owns or leases all such properties as are necessary to the conduct of its operations as presently conducted and such properties are free of any encumbrance.
(ff) Each of the Company and the Specified Subsidiaries (after giving effect to the issuance and sale of the Securities and the application of the proceeds therefrom) is Solvent. As used in this paragraph, the term “Solvent” means that (i) the present fair market value (or present fair saleable value) of the assets of the Company or any Specified Subsidiary is not less than the total amount required to pay the liabilities of the Company or such Specified Subsidiary on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured, (ii) in light of their current financial circumstances, each of the Company and the Specified Subsidiaries is able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (iii) assuming consummation of the issuance of the Securities as contemplated by the Disclosure Package, the Prospectus and the Spanish Documents, in light of their current financial circumstances, none of the Company or any of its Specified Subsidiaries is incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature and (iv) neither the Company nor any of its Specified Subsidiaries is
engaged in any business or transaction, or proposes to engage in any business or transaction, for which its property would constitute unreasonably small capital.
(gg) Neither the Company nor any subsidiary is in violation or default of (i) any provision of its charter or by-laws, (ii) the terms of any concession, indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its property is subject, or (iii) any statute, law, rule, regulation, judgment, order or decree of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or such subsidiary or any of its properties, as applicable, except, in the case of (ii) or (iii), for such violations or defaults that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(hh) Except as otherwise set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), there are no acquisitions or disposals of businesses or assets by the Company or its subsidiaries pending or currently being negotiated which would be or might reasonably be expected to be material in the context of the issue of the Offered Shares or which might require a public announcement to be made by the Company.
(ii) Except as otherwise set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), neither the Company nor any of its subsidiaries has any material off balance sheet financing.
(jj) Deloitte, S.L., who have certified certain financial statements of the Company and its consolidated subsidiaries and delivered their report with respect to certain audited consolidated financial statements and related notes included in the Disclosure Package, the Prospectus, the Registration Statement and the Folleto, are independent public accountants with respect to the Company within the meaning of the Act and the applicable published rules and regulations thereunder and the rules and regulations of the U.S. Public Company Accounting Oversight Board and are independent from the Company under Spanish law in accordance with the requirements of the consolidated text of the Audit of Annual Accounts Act, approved by Royal Legislative Decree 1/2011, of July 1 (texto refundido de xx Xxx de Auditoría de Cuentas, aprobado por el Real Decreto Legislativo 1/2011, de 1 de xxxxx), as amended (the “Spanish Audit Act”).
(kk) PricewaterhouseCoopers Auditores, S.L., who have certified certain financial statements of the Company and its consolidated subsidiaries and delivered their report with respect to certain audited consolidated financial statements and related notes included in the Disclosure Package, the Prospectus, the Registration Statement and the Folleto, are independent public accountants with respect to the Company within the meaning of the Act and the applicable published rules and regulations thereunder and the rules and regulations of the U.S. Public Company Accounting Oversight Board and are independent from the Company under Spanish law in accordance with the requirements of the Spanish Audit Act.
(ll) (i) No outstanding indebtedness of the Company or any of its subsidiaries has become due and payable before its stated maturity, nor has any security in respect of such
indebtedness become enforceable by reason of default by the Company or any of its subsidiaries and no event has occurred or is, to the knowledge of the Company, pending that with the passage of time or the giving of notice or the fulfilment of any condition may result in any such indebtedness becoming so due and payable or any such security becoming enforceable; (ii) no person to whom any indebtedness of the Company or any of its subsidiaries which is payable on demand is owed has demanded or threatened to demand repayment of, or to take steps to enforce any security for, such indebtedness; (iii) the amounts borrowed by the Company and each of its subsidiaries do not exceed any limitation on borrowing contained in the constitutive documents, any debenture or other deed or document binding upon such entity; (iv) any waivers received in respect of any indebtedness of the Company and each of its subsidiaries have been validly received and the Company and the relevant subsidiaries are in compliance with the terms thereof; and (v) (A) the borrowing facilities of the Company and each of its subsidiaries have been duly executed and are in full force and effect and (B) all undrawn amounts under such borrowing facilities are or will be capable of being drawn down in accordance with the terms of such borrowing facilities.
(mm) The Company and its subsidiaries have accurately filed all tax returns that are required to be filed in all jurisdictions in which they are required so to file (or have duly requested and been granted extensions of the timing for filing) and have paid all taxes required to be paid by any of them in all jurisdictions and have paid any related assessments, fines or penalties, except where the failure to file such returns and pay such taxes and related assessments, fines or penalties would not, individually or in the aggregate, be material; and, except as otherwise disclosed in the Disclosure Package, the Prospectus and the Spanish Documents, there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets, except where such deficiency would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(nn) No material labor problem or dispute with the employees of the Company or any of its subsidiaries exists or, to the Company’s best knowledge, is threatened or imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries’ principal suppliers, contractors or customers, that could reasonably expected to have a Material Adverse Effect, except as set forth in the Disclosure Package, the Prospectus and the Nota sobre las Acciones (exclusive of any amendment or supplement thereto).
(oo) The Company and each of its subsidiaries are insured by insurers of recognized standing against such losses and risks and in such amounts as are customary in the businesses in which they are engaged; all policies of insurance insuring the Company or any of its subsidiaries or their respective businesses, assets, employees, officers and directors are in full force and effect; the Company and its subsidiaries are in compliance with the terms of such policies and instruments in all material respects; and there are no material claims by the Company or any of its subsidiaries under any such policy or instrument as to which any insurance company has in writing denied liability or defending under a reservation of rights clause; neither the Company nor any such subsidiary has been refused any insurance coverage sought or applied for; and neither the Company nor any such subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not reasonably be expected to have a Material Adverse Effect, except as set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(pp) Except as disclosed in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), under current Spanish laws and regulations, no authorization, approval or consent of any governmental authority or agency of Spain or of any other jurisdiction is required to effect dividend payments or other distributions in respect of the Class B Shares and all dividends and other distributions declared and payable on the Class B Shares may be paid by the Company to the Depositary and to the holders of Offered Shares, as the case may be (whether or not resident in Spain for tax purposes), in euro and may be converted into foreign currency and freely transferred out of Spain in accordance with the Deposit Agreement and are otherwise free and clear of any other tax, duty, withholding or deduction in Spain.
(qq) No subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such subsidiary’s capital stock, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary’s property or assets to the Company or any other subsidiary of the Company, except as described in or contemplated by the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(rr) The Company and its subsidiaries possess all licenses, certificates, permits and other authorizations issued by all applicable authorities necessary to conduct their respective businesses except where the failure to so possess any such license, certificate, permit or other authorization would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, and neither the Company nor any such subsidiary has received any written notice of proceedings relating to the revocation or modification of any such license, certificate, authorization or permit which, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse Effect, except as set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(ss) The concessions described in the Disclosure Package, the Prospectus and the Spanish Documents and entered into between the Company and/or its subsidiaries, on the one hand, and the relevant governmental or regulatory authority, on the other hand: (i) have been duly authorized, executed and delivered and constitute valid and legally binding agreements of the Company and/or such subsidiary, and none of the Company or any of its subsidiaries has received any notice of termination, revocation or modification with respect to any such concession, except for any modification that is described in the Disclosure Package, the Prospectus and the Spanish Documents or any termination, revocation or modification that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; (ii) to the extent such concessions are under construction, they comply in all material respects with all applicable laws and regulations and with their respective concession agreements, except for any non-compliance that, individually or in the aggregate, would not
reasonably be expected to result in a Material Adverse Effect; and (iii) the operating information included in the Disclosure Package, the Prospectus and the Spanish Documents with respect to the concessions entered into between the Company and/or its subsidiaries, on the one hand, and the relevant governmental or regulatory authority, on the other hand has been properly prepared after due and careful enquiry and is accurate in all material respects.
(tt) The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with IFRS as issued by the IASB and IFRS as adopted by the European Union and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and its subsidiaries maintain a system of “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) that complies with the requirements of the Exchange Act and have been designed by, or under the supervision of, management, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS as issued by the IASB. The Company and its subsidiaries’ internal controls over financial reporting are effective and the Company and its subsidiaries are not aware of any material weakness in their internal controls over financial reporting.
(uu) The Company and its subsidiaries maintain “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) under the Exchange Act); such disclosure controls and procedures are effective.
(vv) The statements set forth in each Preliminary Prospectus and the Prospectus under the caption “Related Party Transactions,” in the Documento de Registro in Section 19 and in the Nota sobre las Acciones in Section 11.3 under the heading “Operaciones de partes vinculadas” insofar as they purport to describe all material aspects of the commercial and contractual relationships between the Company and its consolidated subsidiaries, on the one hand, and its controlling shareholders, directors, officers and their respective affiliates, on the other hand, are, in each case, accurate descriptions in all material respects and fairly summarize the transactions and relationships purported to be described therein. There are no further transactions or agreements that would be required to be described in the Disclosure Package, the Prospectus, the Registration Statement or the Spanish Documents under applicable laws that have not been so described. None of the Company or any of its subsidiaries has since January 1, 2010 or is currently engaged in any material transactions with its directors, officers, management, shareholders, or any other person, including persons formerly holding such positions, on terms that are not available from other parties on an arm’s-length basis.
(ww) Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any of its affiliates or any person acting on its or their behalf (other than the Underwriters, as to whom the Company makes no representation) has taken, or will take, directly or indirectly, any action designed to or that would constitute or that might reasonably
be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Offered Shares.
(xx) Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any of its affiliates has, directly or indirectly, in relation to the offering contemplated pursuant to this Underwriting Agreement or otherwise, done any act or engaged in any course of conduct in breach of applicable Spanish regulations on market abuse including the Spanish Act as developed by Royal Decree 1333/2005 (Real Decreto 1333/2005, de 11 de noviembre, por el que se desarrolla xx Xxx 00/0000, xx 00 xx xxxxx, xxx Xxxxxxx xx Xxxxxxx, en materia de abuso xx xxxxxxx), or, to the knowledge of the Company, the equivalent provisions under the securities laws applicable in any other relevant jurisdiction nor, so far as the Company is aware, has any person acting on its behalf or on behalf of any of its affiliates (other than the Underwriters, as to whom the Company makes no representation) done any act or engaged in any course of conduct as described above. The Company has suspended the effectiveness of its liquidity agreement entered into with Santander Investment Bolsa, S.V., S.A. on November 8, 2012 from the date immediately following approval and registration of the Nota sobre las Acciones with the CNMV until the end of the stabilization period provided for in Section 2 hereof.
(yy) Except as otherwise set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), the Company and its subsidiaries (i) are in compliance with any and all applicable European Union, state, local and foreign law (including U.S. federal and state law) and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received and are in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) have not received written notice of any actual or potential liability under any environmental law, except where such non-compliance with Environmental Laws, failure to receive required permits, licenses or other approvals, or liability would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), neither the Company nor any of the subsidiaries has been named as a “potentially responsible party” under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended.
(zz) Each benefit, pension and compensation plan, agreement, policy and arrangement that is maintained, administered or contributed to by the Company or any of its subsidiaries or any of their respective affiliates for current or former employees or directors of, or independent contractors with respect to, the Company or any of its subsidiaries or any of their respective affiliates, or with respect to which any of such entities could reasonably be expected to have any current, future or contingent liability or responsibility, has been maintained in compliance with its terms and requirements of any applicable statutes, orders, rules and regulations. The Company and each of its subsidiaries and each of their respective affiliates have complied with all applicable statutes, orders, rules and regulations in regard to such plans, agreements, policies and arrangements. The present value of all accrued benefits
under each such plan, based on those assumptions used to fund such plan, as calculated by the Company’s actuaries, did not, as of the last annual valuation date prior to the date on which this representation is made, exceed the value of the assets of such plan allocable to such benefits by an amount which could reasonably be expected to have a Material Adverse Effect. The liabilities reflected on the relevant entity’s financial statements with respect to each such plan, agreement, policy and arrangement which is not required or intended to be funded accurately reflects the present value of all benefits earned or accrued or payments due under such plan, agreement, policy or arrangement determined using reasonable actuarial assumptions.
(aaa) In the ordinary course of its business, the Company periodically reviews the effect of Environmental Laws on the business, operations and properties of the Company and its subsidiaries, in the course of which it identifies and evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws, or any permit, license or approval, any related constraints on operating activities and any potential liabilities to third parties). On the basis of such review, the Company has reasonably concluded that such associated costs and liabilities would not, singly or in the aggregate, have a Material Adverse Effect, except as set forth in the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto).
(bbb) None of the following events has occurred or exists: (i) a failure to fulfill the obligations, if any, under the minimum funding standards of Xxxxxxx 000 xx xxx Xxxxxx Xxxxxx Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations and published interpretations thereunder with respect to a Plan, determined without regard to any waiver of such obligations or extension of any amortization period; (ii) an audit or investigation by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other federal or state governmental agency or any foreign regulatory agency with respect to the employment or compensation of employees by any of the Company or any of its subsidiaries that could have a Material Adverse Effect; (iii) any breach of any contractual obligation, or any violation of law or applicable qualification standards, with respect to the employment or compensation of employees by the Company or any of its subsidiaries that could have a Material Adverse Effect.
(ccc) There is and has been no failure on the part of the Company nor, to the Company’s knowledge, any of the Company’s directors or officers, in their capacities as such, to comply with any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the applicable rules and regulations promulgated in connection therewith (the “Xxxxxxxx-Xxxxx Act”), including Section 402 relating to loans.
(ddd) Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”) or of any other applicable law in any applicable jurisdiction which is broadly equivalent to the FCPA or which has as its objective the prevention of corruption, including, without limitation, making use of the mails or any
means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA; and the Company, its subsidiaries and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and any other applicable law in any applicable jurisdiction which is broadly equivalent to the FCPA or which has as its objective the prevention of corruption and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.
(eee) None of the Company, any of its subsidiaries nor, so far as the Company is aware, any director, officer, agent or employee of the Company or any of its subsidiaries or, to the best of the Company’s knowledge, any person acting on its or their behalf has: (i) used, or agreed to use, any corporate funds for any unlawful contribution, gift, entertainment or unlawful expense relating to political activity; (ii) made, or agreed to make, any offer, payment, promise to pay, or authorization of the payment of any money, or offer, gift, promise to give, or authorization of the giving of anything of value to any official or employee of any foreign or domestic government or public international organization (or person acting in an official capacity for or on behalf of any such government or organization) from, in each case, corporate funds or assets; or (iii) paid, or attempted to pay, any bribe, rebate, pay-off, influence payment, kickback or other unlawful payment.
(fff) The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements and the money laundering statutes and the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.
(ggg) Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.
(hhh) The Company and its subsidiaries own or possess adequate licenses or have other rights to use, on reasonable terms, all patents, patent applications, trade and service marks, trade and service xxxx registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property (collectively, the “Intellectual Property”) necessary for the conduct of the Company’s business as now conducted or as proposed in the Prospectus to be conducted. Except as set forth in the
Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), (i) there are no rights of third parties to any such Intellectual Property, except for customary reversionary rights of third-party licensors; (ii) there is no material infringement by third parties of any such Intellectual Property that is disclosed in the Registration Statement, the Disclosure Package, the Prospectus and the Spanish Documents as owned by the Company or its subsidiaries; (iii) there is no pending or, to the Company’s best knowledge, threatened action, suit, proceeding or claim by others (A) challenging the Company’s rights in or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (B) challenging the validity or scope of any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; or (C) that the Company infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others, and the Company is unaware of any other fact which would form a reasonable basis for any such claim; and (iv) there is no prior art of which the Company is aware that may render any U.S. patent held by the Company invalid or any U.S. patent application held by the Company unpatentable which has not been disclosed to the U.S. Patent and Trademark Office.
(iii) Except as disclosed in the Registration Statement, the Disclosure Package, the Prospectus and the Spanish Documents (exclusive of any amendment or supplement thereto), the Company (i) does not have any material lending or other relationship with any bank or lending affiliate of [Citigroup Global Markets Limited, [·] and [·]] and (ii) does not intend to use any of the proceeds from the sale of the Offered Shares hereunder to repay any outstanding debt owed to any affiliate of [Citigroup Global Markets Limited, [·] and [·]].
(jjj) Neither the Company nor any of its subsidiaries nor any of its or their properties or assets has any immunity from the jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution or otherwise) under the laws of Spain.
(kkk) The Company was not a Passive Foreign Investment Company (“PFIC”) within the meaning of Section 1297 of the United States Internal Revenue Code of 1986, as amended, for its most recent taxable year, believes that it will not be a PFIC for its current taxable year and, based on the Company’s current and projected income, assets and activities, it does not expect to be classified as a PFIC in the foreseeable future.
(lll) The Company is not and, after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in the Disclosure Package and the Prospectus, will not be an “investment company” as defined in the Investment Company Act of 1940, as amended.
Any certificate signed by any officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Offered
Shares shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.
2. Purchase and Sale. (a) Subject to the terms and conditions and in reliance upon the representations and warranties set forth in this Underwriting Agreement, the Company agrees, on the Closing Date, to issue and sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company, at a purchase price of €[·] per Class B Share (the “Purchase Price”), the amount of the Underwritten Shares, in the form of Class B Shares or ADSs, set forth opposite such Underwriter’s name in Schedule I to this Underwriting Agreement. In connection with the offering, each Underwriter and any controlling entities and/or any of its affiliates acting as an investor for its own account may take up Underwritten Shares and in that capacity may retain, purchase or sell for its own account such Underwritten Shares and any securities of the Company or related investments and may offer or sell such securities or other investments otherwise than in connection with the offering. Accordingly, references herein or in the Disclosure Package, the Prospectus, the Spanish Documents or the Folleto to the Underwritten Shares being offered or placed should be read as including any offering or placement of such Underwritten Shares to the Underwriters and any relevant affiliate acting in such capacity. The Underwriters do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.
(b) Subject to the terms and conditions and in reliance upon the representations and warranties set forth in this Underwriting Agreement, the Company hereby grants an option to the several Underwriters to purchase, severally and not jointly, up to [·] Option Shares at the Purchase Price. Said option (the “Over-allotment Option”) may be exercised only to cover over-allotments in the sale of the Underwritten Shares by the Underwriters. The Over-allotment Option may be exercised by the Representatives, on behalf of the Underwriters, in whole or in part, only once, at any time on or before the 30th day after the date of this Underwriting Agreement upon written or telegraphic notice by the Representatives to the Company setting forth the number of shares of the Option Shares as to which the several Underwriters are exercising the Over-allotment Option and the date on which such Option Shares are to be subscribed and paid for (any such date, an “Option Closing Date”). The number of Option Shares to be purchased by each Underwriter shall be the same percentage of the total number of shares of the Option Shares to be purchased by the several Underwriters as such Underwriter is purchasing of the Underwritten Shares, subject to such adjustments as you in your absolute discretion shall make to eliminate any fractional shares.
(c) With respect to all or any portion of the Offered Shares to be purchased by the Underwriters pursuant to Sections 2(a) and 2(b), the Representatives, on behalf of the Underwriters, may elect to have ADSs delivered and paid for hereunder in lieu of, and in satisfaction of, the Company’s obligation to sell to the Underwriters, and the Underwriters’ several obligation to purchase, such Offered Shares.
(d) In consideration of the agreements herein by the Underwriters, the Company will, in accordance with the provisions of this Underwriting Agreement, no later than the Closing Time (or, with respect to the Option Shares (if the option provided for in Section 2(b) hereof shall have been exercised after the date of this Underwriting Agreement), the Option Closing Date), pay to the Underwriters an aggregate underwriting
commission of 4.5% of the amount equal to the Purchase Price multiplied by the aggregate number of Class B Shares purchased hereunder pursuant to Section 2(a) and 2(b), together with any VAT or other similar tax chargeable thereon.
(e) All sums payable by the Company under this Underwriting Agreement shall be paid without set-off or counterclaim, and free and clear of and without deduction or withholding for or on account of any present or future taxes, levies, imposts, duties, fees, assessments or other charges of whatever nature imposed by Spain, or by any department, agency or other political subdivision or taxing authority thereof, and all interest, penalties or similar liabilities with respect thereto (“Taxes”), unless such deduction or withholding is required by law. If any Taxes are required by law to be deducted or withheld in connection with any such payment, and only in the case of payments made to an Underwriter which is resident for tax purposes in a country that has entered into a Double Tax Treaty with Spain and is not acting through a permanent establishment in a Spanish territory through which it will be acting for the purposes of this Underwriting Agreement, the Company will increase the amount payable as may be necessary in order that the net amount of such payment received by the relevant Underwriter after the deduction or withholding shall equal the respective amount that would have been received by such Underwriter in the absence of the deduction or withholding. No additional amounts shall be payable hereunder by the Company to an Underwriter in the event that such Underwriter (a) does not provide the Company, within a reasonable time, a certificate of tax residence within the meaning of the relevant Double Tax Treaty entered into with Spain duly issued by the tax authorities of its country of residence and dated not more than twelve months prior to the date on which the relevant amount is due and payable, or (b) operates through a tax haven jurisdiction (as defined in Royal Decree 1080/1991, of July 5, 1991, as amended).
(f) If an Underwriter determines, in its sole discretion, that it has received a refund of any Taxes as to which it has been paid additional amounts pursuant to Section 2(e), it shall pay to the Company an amount equal to such refund (but only to the extent of the additional amounts paid under Section 2(e) with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses (including Taxes) of such Underwriter and without interest (other than any interest paid by the relevant jurisdiction with respect to such refund). The Company, upon the request of such Underwriter, shall repay to such Underwriter the amount paid over pursuant to this paragraph (f) (plus any penalties, interest or other charges imposed by the relevant jurisdiction) in the event that such Underwriter is required to repay such refund to such jurisdiction. Notwithstanding anything to the contrary in this paragraph (f), in no event will the Underwriter be required to pay any amount to the Company pursuant to this paragraph (f) the payment of which would place the Underwriter in a less favorable net after-Tax position than the Underwriter would have been in if the Tax in respect of which additional amounts were paid and giving rise to such refund had not been deducted, withheld or otherwise imposed and the additional amounts paid with respect to such Tax had never been paid. This paragraph shall not be construed to require any Underwriter to make available its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Company or any other person.
(g) In connection with the offering of the Offered Shares, [·] (or its agents) on behalf of itself and the other Underwriters (the “Stabilization Agent”) may, to the extent permitted by applicable laws and regulations, at its discretion, over-allot Class B Shares
(including in the form of ADSs), or effect transactions in any over-the-counter market or otherwise, with a view to supporting the market price of the Class B Shares (including in the form of ADSs), at a level higher than that which might otherwise prevail in the open market. Such transactions may commence on or after the date of commencement of trading of the Offered Shares on the Madrid and Barcelona Stock Exchanges and the ADSs on the Nasdaq Global Select Market and will end no later than 30 calendar days after the date of commencement of trading of the Offered Shares on the Madrid and Barcelona Stock Exchanges and the ADSs on the Nasdaq Global Select Market (the “Stabilization Period”). In so doing, the Stabilization Agent shall act as principal and not as agent for the Company and any loss resulting from stabilization shall be borne, and any profit arising therefrom shall be beneficially retained, by the Stabilization Agent on behalf of itself and the other Underwriters in the manner agreed between them. There is no assurance that such transactions will be undertaken and, if commenced, they may be discontinued at any time. There shall be no obligation on the Stabilization Agent to enter into such transactions . All such stabilization shall be conducted in accordance with applicable laws and regulations (including, when applicable, Commission Regulation (EC) No. 2273/2003). The Company authorizes the Stabilization Agent on behalf of itself and of the other Underwriters to make adequate public disclosure of the information required by Commission Regulation (EC) No. 2273/2003.
3. Delivery and Payment. (a) [·], as pre-funding banks (the “Pre-Funding Banks”), acting in their own name and on behalf of the other Underwriters in the proportion set out opposite their names in Schedule I, shall pay for the Underwritten Shares and the Option Shares (if the Over-allotment Option provided for in Section 2(b) hereof shall have been exercised on the date of this Underwriting Agreement) at the Purchase Price, without deduction of any commissions and expenses (the “Pre-funding Amount”), by 9:00 a.m. Madrid time (the “Pre-funding Time”) on the Madrid business day immediately following the date of this Underwriting Agreement (unless postponed in accordance with the provisions of Section 9 hereof) or on such other time not later than five Madrid business days after such date as shall be agreed upon by the Representatives and the Company (the “Closing Date”) on the terms and conditions and in the manner set forth in Appendix A hereto, which shall be deemed to form an integrated part of this Underwriting Agreement.
(b) If the Over-allotment Option provided for in Section 2(b) hereof is exercised after the date of this Underwriting Agreement, payment for the Option Shares shall be made to the Company in euro by wire transfer of immediately available funds to the Company Account (as such term is defined in Appendix A hereto) on the Option Closing Date. On the Option Closing Date, the Agent Bank (as such term is defined in Appendix A hereto) shall withdraw from, or segregate within, the Company Account sufficient funds (in the amount notified to it by the Representatives) to make payment, on the Option Closing Date, to the [Representatives, for the account of the several] Underwriters, of the aggregate commissions set forth in Section 2 of this Underwriting Agreement in connection with the Option Shares. Delivery of the Option Shares shall be made by the Company within 5 and 15 Madrid business days after the date of exercise of the Over-allotment Option and in the manner contemplated in the Stock Loan Agreement. If the Option Closing Date occurs after the Closing Date, the Company will deliver to the Representatives on the Option Closing Date, and the obligation of the Underwriters to purchase the Option Shares shall be conditioned upon receipt
of, supplemental opinions, certificates and letters confirming as of such date the opinions, certificates and letters delivered on the Closing Date pursuant to Section 6 hereof.
4. Offering by Underwriters. It is understood that the several Underwriters propose to offer the Offered Shares for sale as set forth in the Prospectus.
5. Agreements. The Company agrees with the several Underwriters that:
(a) Prior to the termination of the offering of the Offered Shares, the Company will not file any amendment of the Registration Statement or the ADR Registration Statement or supplement to the Prospectus or the Spanish Documents or any Rule 462(b) Registration Statement unless the Company has furnished you a copy for your review prior to filing and will not file any such proposed amendment or supplement to which you reasonably object. The Company will cause the Prospectus, properly completed, and any supplement thereto to be filed in a form approved by the Representatives with the Commission pursuant to the applicable paragraph of Rule 424(b) within the time period prescribed and will provide evidence satisfactory to the Representatives of such timely filing. The Company will cause the Nota sobre las Acciones to be filed in a form approved by the Representatives with the CNMV pursuant to the Spanish Act on the Closing Date and will provide evidence satisfactory to the Representatives of such timely filing. The Company will promptly advise the Representatives (i) when the Prospectus, and any supplement thereto, shall have been filed (if required) with the Commission pursuant to Rule 424(b) or when any Rule 462(b) Registration Statement or ADR Registration Statement shall have been filed with the Commission, (ii) when, prior to termination of the offering of the Offered Shares, any amendment to the Registration Statement or the ADR Registration Statement shall have been filed or become effective, (iii) of any request by the Commission or its staff for any amendment of the Registration Statement, or any Rule 462(b) Registration Statement or the ADR Registration Statement, or for any supplement to the Prospectus or for any additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the ADR Registration Statement or of any notice objecting to their use or the institution or threatening of any proceeding for that purpose, (v) of the issuance by the CNMV or any court of competent jurisdiction of any stop order suspending the effectiveness of the Folleto or of any notice objecting to its use or the institution or threatening of any proceeding for that purpose and (vi) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Offered Shares for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose. The Company will use its reasonable best efforts to prevent the issuance of any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement, the ADR Registration Statement or the Folleto and, upon such issuance, occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop order or relief from such occurrence or objection, including, if necessary, by filing an amendment to the Registration Statement or a new registration statement and using its reasonable best efforts to have such amendment or new registration statement declared effective as soon as practicable.
(b) If, at any time prior to the filing of the Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made at such time not misleading, the Company will (i) notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii) amend or supplement the Disclosure Package to correct such statement or omission; and (iii) supply any amendment or supplement to you in such quantities as you may reasonably request.
(c) If during (1) any time when a prospectus relating to the Offered Shares is required to be delivered under the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172) or (2) the Stabilization Period, any event occurs as a result of which the Prospectus or the Folleto as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Act or the rules thereunder, or to amend the Spanish Documents to comply with the Spanish Act or the rules thereunder, the Company promptly will (i) notify the Representatives of any such event; (ii) prepare and file with the Commission or the CNMV, as the case may be, subject to the second sentence of paragraph (a) of this Section 5, an amendment or supplement which will correct such statement or omission or effect such compliance; and (iii) supply any supplemented Prospectus or Folleto to you in such quantities as you may reasonably request.
(d) As soon as practicable, the Company will make generally available to its security holders and to the Representatives an earnings statement or statements of the Company and its subsidiaries which will satisfy the provisions of Section 11(a) of the Act and Rule 158 under the Act.
(e) The Company will furnish to the Representatives and counsel for the Underwriters, without charge, upon request, signed copies of the Registration Statement and the ADR Registration Statement (including exhibits thereto) and to each other Underwriter a copy of the Registration Statement and the ADR Registration Statement (without exhibits thereto) and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172) as many copies of each Preliminary Prospectus, the Prospectus and each Issuer Free Writing Prospectus and any supplement thereto, and of each of the Spanish Documents as the Representatives may reasonably request. The Company will pay the expenses of printing or other production of all documents relating to the offering.
(f) The Company will use its reasonable best efforts to arrange, if necessary, for the qualification of the Offered Shares for sale under (or obtain exemptions from the application of) the laws of such jurisdictions as the Representatives may reasonably designate and will maintain such qualifications in effect so long as required for the
distribution of the Offered Shares; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Offered Shares, in any jurisdiction where it is not now so subject.
(g) The Company will not, without the prior written consent of the Representatives, offer, sell, contract to sell, pledge, or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company or any affiliate of the Company or any person in privity with the Company or any affiliate of the Company) directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, any Class A Shares, Class B Shares or ADSs or any securities convertible into, or exercisable, or exchangeable for, Class A Shares, Class B Shares or ADSs; or publicly announce an intention to effect any such transaction, from the date of this Underwriting Agreement to 180 days following the date of commencement of trading of the ADSs on the Nasdaq Global Select Market, provided, however, that the Company may issue and sell (i) the Offered Shares and the Offered Notes; (ii) Class B Shares upon the conversion of securities or the exercise of warrants outstanding at the Execution Time and upon the conversion of the Offered Notes, including, without limitation, upon the conversion of Class A Shares into Class B Shares pursuant to the right of conversion approved by the Extraordinary General Shareholders’ Meeting of the Company on September 20, 2012 in connection with the increase in the Company’s Class B share capital; and (iii) Class A Shares, Class B Shares or ADSs pursuant to any employee stock option plan, stock ownership plan or dividend reinvestment plan of the Company in effect at the Execution Time, including, without limitation, pursuant to the filing by the Company of any registration statement on Form S-8 with the Commission relating to the offering of securities pursuant to the terms of such incentive or similar plans. Notwithstanding the foregoing, if (x) during the last 17 days of the 180-day restricted period, the Company issues an earnings release or material news or a material event relating to the Company occurs, or (y) prior to the expiration of the 180-day restricted period, the Company announces that it will release earnings results during the 16-day period beginning on the last day of the 180-day restricted period, the restrictions imposed in this clause shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event. The Company will provide the Representatives and any Underwriters and each individual subject to the restricted period pursuant to the lock-up letters described in Section 6(s) hereof with prior notice of any such announcement that gives rise to an extension of the restricted period.
(h) The Company will comply with all applicable securities and other applicable laws, rules and regulations, including, without limitation, the Sarbanes Oxley Act, and will use its best efforts to cause the Company’s directors and officers, in their capacities as
such, to comply with such laws, rules and regulations, including, without limitation, the provisions of the Sarbanes Oxley Act.
(i) If the Representatives, in their sole discretion, agree to release or waive the restrictions set forth in the lock-up letters described in Section 6(s) hereof for an officer or director of the Company and provide the Company with notice of the impending release or waiver at least three Business Days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit B hereto through a major news service at least two Business Days before the effective date of the release or waiver.
(j) The Company will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Class B Shares or the ADSs, nor will it engage in any course of conduct in breach of applicable Spanish regulations on market abuse including the Spanish Act as developed by Royal Decree 1333/2005 (Real Decreto 1333/2005, de 11 de noviembre, por el que se desarrolla xx Xxx 00/0000, xx 00 xx xxxxx, xxx Xxxxxxx xx Xxxxxxx, en materia de abuso xx xxxxxxx).
(k) The Company agrees to pay the costs and expenses relating to the following matters: (i) the preparation, printing or reproduction and filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), each Preliminary Prospectus, the Disclosure Package, the Prospectus and each Issuer Free Writing Prospectus, the ADR Registration Statement, and each amendment or supplement to any of them; (ii) the preparation, printing or reproduction and filing with the CNMV of the Spanish Documents (including financial statements and exhibits thereto and each amendment or supplement to them); (iii) the preparation of the Deposit Agreement, the deposit of the Underlying Shares under the Deposit Agreement, the issuance thereunder of ADSs representing such deposited Underlying Shares, the issuance of ADRs evidencing such ADSs and the fees of the Depositary; (iv) the preparation of the Stock Loan Agreement; (v) the printing (or reproduction) and delivery (including postage, air freight charges and charges for counting and packaging) of such copies of the Registration Statement, each Preliminary Prospectus, the Prospectus and each Issuer Free Writing Prospectus, the ADR Registration Statement, and all amendments or supplements to any of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of the Offered Shares; (vi) the preparation, printing, authentication, issuance and delivery of certificates for the Offered Shares, including any stamp or transfer taxes in connection with the original issuance and sale of the Offered Shares; (vii) the printing (or reproduction) and delivery of this Underwriting Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered in connection with the offering of the Offered Shares; (viii) the registration of the Offered Shares with the Mercantile Registry and Iberclear; (ix) the registration of the Class B Shares under the Exchange Act and the listing of the Offered Shares on the Madrid and Barcelona Stock Exchanges and the ADSs on the Nasdaq Global Select Market or any other stock exchange; (x) any registration or qualification of the Offered Shares for offer and sale under the securities or blue sky laws of the several states (including filing fees and the
reasonable and documented fees and expenses of counsel for the Underwriters relating to such registration and qualification); (xi) any filings required to be made with the Financial Industry Regulatory Authority, Inc. (including filing fees and the reasonable and documented fees and expenses of counsel for the Underwriters relating to such filings); (xii) the transportation and other expenses incurred by or on behalf of Company representatives in connection with presentations to prospective purchasers of the Offered Shares, including any road show presentation; (xiii) the fees and expenses of the Company’s accountants, the fees and expenses of the auditors appointed by the Mercantile Registry for the purpose of issuing the special report pursuant to articles 308 and 506 of the Spanish Capital Companies Act and the reasonable and documented fees and expenses of counsel (including local and special counsel) for the Company; (xiv) the fees and expenses of U.S. and Spanish counsel for the Underwriters up to the amounts separately agreed by such counsel and the Company, and the fees and expenses of Canadian and any other local counsel for the Underwriters, (xv) the reasonable and documented out-of-pocket expenses of the Underwriters that shall have been incurred by them in connection with the proposed purchase and sale of the Offered Shares, including the transportation and other expenses incurred by or on behalf of the Underwriters representatives in connection with presentations to prospective purchasers of the Offered Shares (including expenses incurred in connection with any road show presentation, to the extent such expenses were previously estimated and communicated to the Company); and (xvi) all other duly-justified costs and expenses incident to the performance by the Company of their obligations hereunder.
(l) The Company agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter, severally and not jointly, agrees with the Company that, unless it has or shall have obtained, as the case may be, the prior written consent of the Company, it has not made and will not make any offer relating to the Offered Shares that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405) required to be filed by the Company with the Commission or retained by the Company under Rule 433; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule II hereto and any electronic road show. Any such free writing prospectus consented to by the Representatives or the Company is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
(m) The Company shall not distribute any offering materials in connection with the offering of the Offered Shares other than the Registration Statement, any Preliminary Prospectus, any Permitted Free Writing Prospectus, the Disclosure Package, the Prospectus and the Spanish Documents, and pricing information or other materials, if any, consented to in advance by the Representatives.
6. Conditions to the Obligations of the Underwriters. The obligations of the Underwriters to purchase the Underwritten Shares and the Option Shares, as the case may be, shall be subject to the accuracy of the representations and warranties on the part of the Company contained in this Underwriting Agreement as of the Execution Time, the Pre-funding Time, the Closing Date, the Settlement Date and the Option Closing Date, if any, pursuant to Section 3 hereof, to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance by the Company of its obligations under this Underwriting Agreement and to the following additional conditions:
(a) The Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule 424(b); any material required to be filed by the Company pursuant to Rule 433(d) under the Act shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement or the ADR Registration Statement or any notice objecting to their use shall have been issued and no proceedings for that purpose shall have been instituted or threatened, and the Folleto has been filed in the manner and within the time period established by the Spanish Act as developed by secondary legislation and no stop order suspending the effectiveness of the Folleto or any notice objecting to its use shall have been issued and no proceedings for that purpose shall have been instituted or threatened.
(b) KPMG Auditores, S.L. (“KPMG”) has issued by not later than 11:59 p.m. (Madrid time) on the date hereof its special report for the purposes of articles 308 and 506 of the Spanish Capital Companies Act confirming that the Purchase Price is at a “fair value” and that the figures contained in the report of the Board of Directors of the Company on the capital increase relating to the Offered Shares are, in their view, reasonable and take into account the value of the pre-emptive subscription rights of the shareholders of the Company that will be excluded with respect to the capital increase relating to the Offered Shares.
(c) The Company shall have requested and caused DLA Piper Spain, S.L.U. and DLA Piper LLP (US), counsel for the Company with respect to Spanish and U.S. law, respectively, to have furnished to the Representatives their opinion or opinions, as the case may be, dated the Closing Date and addressed to the Representatives, to the effect that (subject to assumptions and qualifications reasonably acceptable to the Representatives):
(i) the Registration Statement and the ADR Registration Statement have become effective under the Act; any required filing of the Prospectus, and any supplements thereto, pursuant to Rule 424(b) has been made in the manner and within the time period required by Rule 424(b); to the knowledge of such counsel, no stop order suspending the effectiveness of the Registration Statement or the ADR Registration Statement or any notice objecting to their use has been issued, no proceedings for that purpose have been instituted or threatened, and the Registration Statement and the ADR Registration Statement and the Prospectus (other than the financial statements and other financial and statistical information contained therein, as to which such counsel need express no opinion) comply as to form in all material respects with the applicable requirements of the Act and the rules thereunder; and such counsel has no reason to believe that on the Effective Date or the date the Registration Statement was last deemed amended the Registration Statement or the ADR Registration Statement contained any untrue
statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading or that the Prospectus as of the date thereof and on the Closing Date included or includes any untrue statement of a material fact or omitted or omits to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (in each case, other than the financial statements and other financial and statistical information contained therein, as to which such counsel need express no opinion);
(ii) such counsel has no reason to believe that the Disclosure Package, as amended or supplemented at the Execution Time, contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading (other than the financial statements and other financial information contained therein, as to which such counsel need express no opinion);
(iii) the Documento de Registro was approved and registered by the CNMV pursuant to the Spanish Act on July 12, 2012, the Company filed with the CNMV the Relevant Fact Notice on the details of the Offering on [·]; to the knowledge of such counsel, no stop order suspending the effectiveness of the Documento de Registro has been issued, no proceedings for that purpose have been instituted or threatened and the Folleto (other than the financial statements and other financial and statistical information contained therein, as to which such counsel need express no opinion) comply as to form in all material respects with the applicable requirements of the Spanish Act and the rules thereunder; and such counsel has no reason to believe that on the Effective Date or the date the Folleto was last deemed amended the Spanish Documents contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading or that the Folleto as of the date thereof and on the Closing Date included or include any untrue statement of a material fact or omitted or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (in each case, other than the financial statements and other financial and statistical information contained therein, as to which such counsel need express no opinion);
(iv) each of the Company and the Specified Subsidiaries has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction in which it is chartered or organized, with full corporate power and authority to own or lease, as the case may be, and to operate its properties and conduct its business as described in the Disclosure Package, the Prospectus and the Documento de Registro, and is duly qualified to do business as a foreign corporation and is in good standing under the laws of each jurisdiction which requires such qualification except where the failure to be so qualified or in good standing would not have a Material Adverse Effect;
(v) each of the Lock-Up Agreement Signatories (as hereinafter defined) that is a corporate entity has been duly incorporated and is validly existing as a [corporation] in good standing under the laws of the jurisdiction in which it is chartered or organized,
with full corporate power and authority to enter into the Lock-Up Agreement, and each of the Lock-Up Agreement Signatories that is an individual has due authority to enter into the Lock-Up Agreement;
(vi) all the outstanding shares of capital stock of each Specified Subsidiary have been duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise set forth in the Disclosure Package and the Prospectus, all outstanding shares of capital stock of each such Specified Subsidiary are owned by the Company either directly or through wholly owned subsidiaries free and clear of any perfected security interest or, to the knowledge of such counsel, after due inquiry, any other security interest, claim, lien or encumbrance;
(vii) the Company’s authorized share capital is as set forth in the Disclosure Package, the Prospectus and the Spanish Documents; the capital stock of the Company conforms in all material respects to the description thereof contained in the Disclosure Package, the Prospectus and the Spanish Documents; the outstanding Class A Shares and Class B Shares have been duly and validly authorized and issued and are fully paid and nonassessable; the Offered Shares being sold under this Underwriting Agreement by the Company have been duly and validly authorized, and, when issued and delivered to and paid for by the Underwriters pursuant to this Underwriting Agreement, and when the capital increase relating to the Offered Shares has been duly registered with the Mercantile Registry and the Offered Shares have been duly registered with Iberclear, the Offered Shares will be fully paid and nonassessable; the ADSs being sold under the Underwriting Agreement by the Company are duly authorized for trading, subject to official notice of issuance and evidence of satisfactory distribution, on the Nasdaq Global Select Market and application has been made for the Offered Shares to be duly admitted to listing on each of the Madrid and Barcelona Stock Exchanges and authorized for trading on the SIB; the Offered Shares will conform in all material respects to the description thereof contained in the Registration Statement, the ADR Registration Statement, the Disclosure Package, the Prospectus and the Spanish Documents; the holders of outstanding shares of capital stock of the Company and of bonds convertible into Class A Shares or Class B Shares of the Company are not entitled to preemptive or other rights to subscribe for the Offered Shares other than those as have been duly excluded in accordance with Spanish law; and, except as set forth in the Disclosure Package and the Prospectus, no options, warrants or other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations into or exchange any securities for, shares of capital stock of or ownership interests in the Company are outstanding and there are no commitments by the Company to create, issue, sell or otherwise dispose of, shares of capital stock of or ownership interests in the Company;
(viii) insofar as matters of Spanish law, United States Federal law and New York State law are concerned, to the knowledge of such counsel, there is no pending or threatened action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries or its or their property of a character required to be disclosed in the Registration Statement, the ADR Registration Statement or the Spanish Documents which is not adequately disclosed in the Disclosure Package, the Prospectus and the Spanish Documents, and there is no
franchise, contract or other document of a character required to be described in the Registration Statement, the ADR Registration Statement, the Disclosure Package, the Prospectus or the Spanish Documents, or to be filed as an exhibit thereto, which is not described or filed as required; the descriptions contained in the Prospectus under the heading “Taxation,” insofar as such statements summarize legal conclusions applicable to the offering of the Class B Shares and ADSs, constitute fair and accurate summaries of such legal matters; and the statements in the Prospectus under the headings “Business—Intellectual Property,” “Business—Information Technology,” “Business—Legal Proceedings,” “Regulation,” “Description of Share Capital,” “Description of the Share Lending Arrangements” and “Description of American Depositary Shares” in the Documento de Registro (as of its date) in Sections 2, 5.2, 6, 8, 10, 11, 19, 20, 21 and 22, and in the Nota sobre las Acciones (as of its date) in Sections 3.3, 4, 5, 6, 7.3, 10.2, 10.3, 11.1 and 11.3, insofar as such statements summarize legal matters, agreements, documents or proceedings discussed therein, are accurate and fair summaries of such legal matters, agreements, documents or proceedings;
(ix) this Underwriting Agreement has been duly authorized, executed and delivered by the Company;
(x) the agency agreement entered into by the Company with [·] (the “Agency Agreement”) has been duly authorized, executed and delivered by the Company and the obligations assumed thereunder by the Company are legal, valid, binding and enforceable obligations of the Company;
(xi) the Stock Loan Agreement has been duly authorized, executed and delivered by Inversión Corporativa IC, S.A. and the obligations assumed thereunder by Inversión Corporativa IC, S.A. are legal, valid, binding and enforceable obligations of Inversión Corporativa IC, S.A.;
(xii) the Lock-Up Agreements have been duly authorized, executed and delivered by the Lock-Up Agreement Signatories;
(xiii) the Company is not and, after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in the Prospectus, will not be, an “investment company” as defined in the Investment Company Act of 1940, as amended;
(xiv) no consent, approval, authorization, filing with or order of any Spanish, U.S. Federal or New York court or governmental agency or body is required in connection with the transactions contemplated in the Underwriting Agreement, in the Deposit Agreement or in the Stock Loan Agreement, except (A) such as have been obtained under the Act and the Spanish Capital Companies Act, (B) such as may be required under the blue sky laws of any jurisdiction in connection with the purchase and distribution of the Offered Shares by the Underwriters in the manner contemplated in this Underwriting Agreement, in the Disclosure Package and the Prospectus, (C) the registration of the Nota sobre las Acciones and complementary documentation with the CNMV, (D) the formalization of the capital increase by means of a public deed granted before a Spanish
notary public, the filing by the Company with the relevant Spanish tax authorities as exempt from capital tax (Impuesto sobre Transmisiones Patrimoniales y Actos Jurídicos Documentados en su modalidad de Operaciones Societarias) and the registration of such public deed with the Mercantile Registry, (E) the registration of the Offered Shares with Iberclear and the verification of the listing of the Offered Shares by the CNMV, (F) the approval of the listing of the Offered Shares by the relevant managing entities (Sociedades Rectoras) of each of the Madrid and Barcelona Stock Exchanges, and (G) the approval of the admission of the Offered Shares to trading through the SIB by the CNMV;
(xv) none of the issue and sale of the Offered Shares, the consummation of any other of the transactions contemplated herein, in the Deposit Agreement or in the Stock Loan Agreement and the fulfillment of the terms hereof, of the Deposit Agreement or of the Stock Loan Agreement, will conflict with, result in a breach or violation of, or imposition of any lien, charge or encumbrance upon any property or assets of the Company or its subsidiaries pursuant to, (A) the charter or by-laws of the Company or its subsidiaries, (B) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument [identified on the annexed schedule] to which the Company or its subsidiaries is a party or bound or to which its or their property is subject, or (C) any Spanish, U.S. Federal or New York state statute, law, rule, regulation, judgment, order or decree applicable to the Company or its subsidiaries of any Spanish, U.S. Federal or New York court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or its subsidiaries or any of its or their properties;
(xvi) no holders of securities of the Company have rights to the registration of such securities under the Registration Statement or the ADR Registration Statement;
(xvii) the Deposit Agreement has been duly authorized, executed and delivered by the Company and constitutes a legal, valid and binding instrument enforceable against the Company in accordance with its terms (subject, as to enforcement of remedies, to applicable bankruptcy, reorganization, insolvency, moratorium or other laws affecting creditors’ rights generally from time to time in effect and subject, as to enforceability, to general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law)); and the statements in the Prospectus under the heading “Description of American Depositary Shares,” insofar as such statements purport to summarize certain provisions of the Deposit Agreement, the ADSs and the ADRs, fairly and accurately summarize such provisions; and, upon issuance by the Depositary of the ADRs evidencing ADSs, against the deposit of the Underlying Shares in accordance with the provisions of the Deposit Agreement, the ADRs will be duly and validly issued and the persons in whose names such ADRs are registered will be entitled to the rights specified therein and in the Deposit Agreement;
(xviii) to ensure the legality, validity, enforceability or admissibility into evidence of each of the Underwriting Agreement, the Deposit Agreement and any other document required to be furnished hereunder or thereunder in Spain, it is not necessary that the
Underwriting Agreement, the Deposit Agreement or any such other document be filed or recorded with any court or other authority in Spain, provided such documents are executed outside of Spain, or that any stamp, registration or similar tax be paid on or in respect of any such document or the Class B Shares or the ADSs in connection with the sale of Offered Shares to the Underwriters;
(xix) the submission of the Company to the non-exclusive jurisdiction of the New York Courts and the appointment of [name of designee] as its designee, appointee and authorized agent for the purpose described in Section 18 of this Underwriting Agreement and in the Deposit Agreement are legal, valid and binding under the laws of the State of New York;
(xx) the choice of law provision set forth in Section 16 of this Underwriting Agreement and in the Deposit Agreement is legal, valid and binding under the laws of Spain and such counsel knows of no reason why the courts of Spain would not give effect to the choice of New York law as the proper law of the Underwriting Agreement and of the Deposit Agreement; the Company has the legal capacity to xxx and be sued in its own name under the laws of Spain; the Company has the power to submit, and has irrevocably submitted, to the non-exclusive jurisdiction of the New York Courts and has validly and irrevocably appointed [name of designee] as its designee, appointee and authorized agent for the purpose described in Section 18 of this Underwriting Agreement and in the Deposit Agreement under the laws of Spain; the irrevocable submission of the Company to the non-exclusive jurisdiction of the New York Courts and the waivers by the Company of any immunity and any objection to the venue of the proceeding in a New York Court in the Underwriting Agreement and in the Deposit Agreement are legal, valid and binding under the laws of Spain and such counsel knows of no reason why the courts of Spain would not give effect to the submission and waivers; service of process in the manner set forth in Section 18 of this Underwriting Agreement and in the Deposit Agreement, will be effective to confer valid personal jurisdiction over the Company under the laws of Spain; and the courts in Spain will recognize as valid and final, and will enforce, any final and conclusive judgment against the Company obtained in a New York Court arising out of or in relation to the obligations of the Company under the Underwriting Agreement or the Deposit Agreement;
(xxi) The choice of Spanish law to govern the Agency Agreement is legal, valid and binding under the laws of the State of New York and such counsel knows of no reason why the state or federal courts in the State of New York would not give effect to the choice of Spanish law as the proper law of the Agency Agreement; and the submission of the Company in the Agency Agreement to the jurisdiction of Spanish courts is valid, binding and enforceable;
(xxii) no stamp or other issuance or transfer taxes or duties are payable by or on behalf of any Underwriter in connection with (A) the delivery of the Offered Shares in the manner contemplated by the Underwriting Agreement, (B) the deposit with the Depositary of the Underlying Shares against issuance of the ADRs evidencing the ADSs, (C) the sale and delivery by each such Underwriter of the Offered Shares, including in the
form of ADSs, as contemplated in the Underwriting Agreement, or (D) the transactions contemplated by the Stock Loan Agreement; and
(xxiii) other than as described in the Disclosure Package and the Prospectus, under the current laws and regulations of Spain, all dividends and other distributions declared and payable on the Offered Shares may be paid by the Company to the Depositary and to the holders of ADSs, as applicable, in Euro that may be converted into foreign currency and freely transferred out of Spain, and all such dividends and other distributions made to holders of the Offered Shares (or the ADSs representing such securities) who are non-residents of Spain will not be subject to income, withholding or other taxes under the laws and regulations of Spain and are otherwise free and clear of any other tax, duty withholding or deduction in Spain and without the necessity of obtaining any governmental authorization in Spain.
For the avoidance of doubt, the opinions in (i) and (ii) above shall be delivered in respect of U.S. law by DLA Piper LLP (US) in New York, New York. In rendering such opinion, such counsel may rely (A) as to matters involving the application of laws of any jurisdiction other than the Kingdom of Spain, the Federal laws of the United States and the State of New York, to the extent they deem proper and specified in such opinion, upon the opinion of other counsel of good standing whom they believe to be reliable and who are, and whose opinion is, satisfactory to counsel for the Underwriters and (B) as to matters of fact, to the extent they deem proper, on certificates of responsible officers of the Company and public officials. References to the Prospectus in this paragraph (c) shall also include any supplements thereto at the Closing Date.
(d) The Depositary shall have requested and caused Xxxxxxxxx Xxxxxxx Xxxx & Xxxxx LLP, counsel for the Depositary, to have furnished to the Representatives their opinion dated the Closing Date and addressed to the Representatives, to the effect that:
(i) the Deposit Agreement has been duly authorized, executed and delivered by the Depositary and constitutes a legal, valid and binding instrument enforceable against the Depositary in accordance with its terms (subject, as to enforcement of remedies, to applicable bankruptcy, reorganization, insolvency, moratorium or other laws affecting creditors’ rights generally from time to time in effect); the statements in each Preliminary Prospectus and the Prospectus under the heading “Description of American Depositary Shares,” insofar as such statements purport to describe the Depositary and summarize certain provisions of the Deposit Agreement, the ADSs and the ADRs are fair and accurate; and
(ii) the Depositary has full power and authority and legal right to execute and deliver the Deposit Agreement and to perform its obligations thereunder; and
(iii) the ADRs and the ADSs evidenced thereby are in valid and sufficient form and, when issued under the Deposit Agreement, the ADRs will entitle the holders thereof to the rights specified therein and in the Deposit Agreement; and
(iv) the ADR Registration Statement has become effective under the Act and, to the knowledge of such counsel, no stop order suspending the effectiveness of the ADR
Registration Statement or any notice objecting to its use has been issued, no proceedings for that purpose have been instituted or threatened, and the ADR Registration Statement, and each amendment comply as to form in all material respects with the applicable requirements of the Act and the rules thereunder.
(e) The Representatives shall have received from Xxxxx Xxxx & Xxxxxxxx LLP, U.S. counsel for the Underwriters, such U.S. law opinion or opinions, dated the Closing Date and addressed to the Representatives, with respect to the issuance and sale of the Offered Shares, the Registration Statement, the ADR Registration Statement, the Disclosure Package, the Prospectus (together with any supplement thereto) and other related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(f) The Representatives shall have received from Xxxxx-Xxxxxx Abogados, S.L.P. y Cía. S. Com. P., Spanish counsel for the Underwriters, such Spanish law opinion or opinions, dated the Closing Date and addressed to the Representatives, with respect to the issuance and sale of the Offered Shares, the Registration Statement, the ADR Registration Statement, the Disclosure Package, the Prospectus (together with any supplement thereto), the Spanish Documents and other related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(g) The Company shall have furnished to the Representatives a certificate of the Company, executed by the Secretary of the Board and the Chairman of the Board of Directors, of the resolutions passed by the Annual General Meeting of the Company on April 7, 2013 and by the Board of Directors on [·] authorizing, among other things, the issuance of the Offered Shares, the application for admission to listing of the Offered Shares on each of the Madrid and Barcelona Stock Exchanges and of the ADSs on the Nasdaq Global Select Market and the execution by the Company of this Underwriting Agreement and the Deposit Agreement.
(h) The Company shall have furnished to the Representatives a certificate of the Company, signed by the Chairman of the Board or the Consejero Delegado and the principal financial or accounting officer of the Company, dated the Closing Date, to the effect that the signers of such certificate have carefully examined the Registration Statement, the ADR Registration Statement, the Disclosure Package, the Prospectus, and any amendment or supplement thereto, as well as each electronic road show used in connection with the offering contemplated hereby, the Folleto and the Underwriting Agreement and that:
(i) the representations and warranties of the Company in the Underwriting Agreement are true and correct on and as of the Closing Date with the same effect as if made on the Closing Date and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness or use of the Folleto, the Registration Statement or the ADR Registration Statement, nor any notice objecting to
their respective use, has been issued and no proceedings for that purpose have been instituted or, to the Company’s knowledge, threatened; and
(iii) since the date of the most recent financial statements included in the Disclosure Package, the Prospectus, the Registration Statement and the Nota sobre las Acciones (exclusive of any amendment or supplement thereto), there has been no Material Adverse Effect, except as set forth in or contemplated in the Disclosure Package, the Prospectus, the Registration Statement and the Nota sobre las Acciones (exclusive of any amendment or supplement thereto).
(i) The Company shall have furnished to the Representatives a certificate of the Company, executed by the Chief Accounting Officer with respect to certain financial and other information contained in the Prospectus, to the effect that: [·].
(j) The Company shall have requested and caused Deloitte, S.L., to have furnished to the Representatives letters, at the Execution Time and at the Closing Date, dated respectively as of the Execution Time and as of the Closing Date, in form and substance satisfactory to the Representatives, to the effect that: [·].
(k) The Company shall have requested and caused PricewaterhouseCoopers Auditores, S.L., to have furnished to the Representatives letters, at the Execution Time and at the Closing Date, dated respectively as of the Execution Time and as of the Closing Date, in form and substance satisfactory to the Representatives, to the effect that: [·].
(l) Inversión Corporativa IC, S.A. shall have entered into, at or prior to the date hereof, the Stock Loan Agreement and shall have performed all of its obligations thereunder to be performed by it on or prior to the Closing Date.
(m) Subsequent to the Execution Time or, if earlier, the dates as of which information is given in the Registration Statement, the ADR Registration Statement, the Preliminary Prospectus, the Prospectus and the Folleto (in each case, exclusive of any amendment or supplement thereto), there shall not have been (i) any change or decrease specified in the letter or letters referred to in paragraphs (j) and (k) of this Section 6 or (ii) any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise), earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto) the effect of which, in any case referred to in clause (i) or (ii) above, is, in the sole judgment of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Offered Shares as contemplated by the Registration Statement (exclusive of any amendment thereof), the ADR Registration Statement, the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto).
(n) The Company and the Depositary shall have executed and delivered the Deposit Agreement in form and substance satisfactory to the Representatives and the Deposit Agreement shall be in full force and effect.
(o) The Depositary shall have furnished or caused to be furnished to the Representatives certificates satisfactory to the Representatives evidencing the deposit with the Custodian of the Underlying Shares in respect of which ADSs to be purchased by the Underwriters on such Closing Date are to be issued, and the execution, issuance, countersignature (if applicable) and delivery of the ADRs evidencing such ADSs pursuant to the Deposit Agreement and such other matters related thereto as the Representatives reasonably requests.
(p) Subsequent to the Execution Time, there shall not have been any decrease in the rating of any of the Company’s debt securities by any “nationally recognized statistical rating organization” (as defined for purposes of Rule 436(g) under the Act) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change.
(q) The ADSs shall have been authorized for trading on the Nasdaq Global Select Market, subject to official notice of issuance, and satisfactory evidence of such actions shall have been provided to the Representatives.
(r) All steps necessary for the Offered Shares to be admitted to listing on each of the Madrid and Barcelona Stock Exchanges and authorized for trading on the SIB shall have been taken, and satisfactory evidence of such actions shall have been provided to the Representatives.
(s) Prior to the Execution Time, the Company shall have furnished to the Representatives a letter, addressed to the Representatives, substantially in the form of Exhibit A hereto (each such letter, a “Lock-Up Agreement”), from each of the following persons: [the Company, Inversión Corporativa I.C., S.A., Finarpisa, S.A., Xx. Xxxxxx Xxxxxxxx Xxxxxxxx, Aplicaciones Digitales S.L., Xx. Xxxx X. Xxxxxxxx Xxxxx, Xx. Xxxxxx Xxxxxxx Xxxxxx, Xx. Xxxx Xxxxxxx Xxxxxxx Xxxxxxxx, Xx. Xxxx Xxxx Aya Abaurre, Xx. Xxxx Xxxxxxx Fontelles, Ms. Mª Xxxxxx Xxxxxxxx Xxxxxxxx, Xx. Xxxxxx Xxxxxxxx Xxxxxxxx, Xx. Xxxxxxxx Xxxxxx Xxxx, Xx. Xxxxxxx Xxxxx Xxxxxxxxx, Xx. Xxxxxxxx Xxxxx Xxxxxxxx-Xxxxxx, Xx. Xxxxxx Xxxxxxx Xxxxxxxx, Xx. Xxxxxx Xxxxxxxx Xxxxxx, Xx. Xxxxxx Xxxxxxxx Ponsa and Mr. Xxxxxxx Xxxxxxxx Rico], and each of the senior managers listed in section [14.1] of the Documento de Registro, as updated by the Nota sobre las Acciones (such persons, collectively, the “Lock-Up Agreement Signatories”).
(t) Prior to the Closing Date, the Company shall have furnished to the Representatives such further information, certificates and documents as the Representatives may reasonably request.
If any of the conditions specified in this Section 6 shall not have been fulfilled (or waived by the Representatives in the name and on behalf of the Underwriters) when and as provided in this Underwriting Agreement, or if any of the opinions and certificates mentioned above or elsewhere in this Underwriting Agreement shall not be reasonably satisfactory in form and substance to the Representatives and counsel for the Underwriters, this Underwriting Agreement and all obligations of the Underwriters hereunder may be terminated at, or at any time prior to, the Closing Date by the Representatives. Notice of such termination shall be given to the Company in writing or by telephone or facsimile confirmed in writing.
The documents required to be delivered by this Section 6 shall be delivered at the office of Xxxxx Xxxx & Xxxxxxxx LLP, counsel for the Underwriters, at Xxxxx xx xx Xxxxxxxxxx, 00, Xxxxxx 00000, Xxxxx, on the Closing Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Offered Shares provided for in this Underwriting Agreement is not consummated because any condition to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied, because of any termination pursuant to Section 10 hereof or because of any refusal, inability or failure on the part of the Company to perform any agreement in this Underwriting Agreement or comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters severally through the Representatives on demand for all reasonable and documented expenses (including fees and disbursements of U.S., Spanish and Canadian counsel) that shall have been incurred by them in connection with the proposed purchase and sale of the Offered Shares.
8. Indemnification and Contribution. (a) The Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Act or the Exchange Act and each affiliate of any Underwriter within the meaning of the Act against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Act, the Exchange Act or other U.S. federal or state statutory law or regulation, at common law, under any non-U.S. law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement as originally filed or in any amendment thereof, or in the ADR Registration Statement as originally filed or in any amendment thereof, or in any Preliminary Prospectus, the Disclosure Package, any Issuer Free Writing Prospectus or any Prospectus, or in any amendment thereof or supplement thereto, or any road show presentation of the Company, or in the Spanish Documents or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses properly incurred by it in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b). This indemnity agreement will be in addition to any liability which the Company may otherwise have.
(b) Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement, or the ADR Registration Statement, and each person who controls the Company within the meaning of either the Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company to each Underwriter, but only with reference to written information
relating to such Underwriter furnished to the Company by or on behalf of such Underwriter through the Representatives specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability which any Underwriter may otherwise have. The Company acknowledges that [(i) the statements regarding delivery of the Offered Shares in the paragraph of the cover page and in the paragraph under the heading “Underwriting,” (ii) the list of Underwriters and their respective participation in the sale of the Offered Shares, (iii) the sentences related to concessions and reallowances in the paragraph under the heading “Underwriting” and (iv) the statements regarding stabilization in the paragraph under the heading “Underwriting” in each Preliminary Prospectus, the Disclosure Package and the Prospectus and the information contained in Section 6.5 of the Nota sobre las Acciones constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion in the Registration Statement, the ADR Registration Statement, each Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or the Spanish Documents.
(c) Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); provided, however, that such counsel shall be satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the properly incurred fees, costs and expenses of such separate counsel if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with an actual or potential conflict of interest, (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, (iii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action, (iv) the indemnifying party shall authorize the indemnified party to employ separate counsel at the expense of the indemnifying party, (v) an Underwriter (in respect of a claim against it or any of its indemnified parties) gives notice to an indemnifying party that its insurers require it not to allow such participation or assumption of (or continued participation in or assumption of) the defense of the action or (vi) if in the reasonable judgment of an indemnified party its position and interests would be adversely affected by the indemnifying party’s participation in or assumption of (or continued participation in or assumption of) the
defense of such action. It is understood and agreed that the indemnifying party shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local and/or regulatory counsel) for all indemnified parties, and that all such fees and expenses shall be paid or reimbursed as they are incurred. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding, and (ii) does not include any statement as to an admission of fault, culpability or failure to act by or on behalf of any indemnified party.
(d) In the event that the indemnity provided in paragraph (a), (b) or (c) of this Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses properly incurred in connection with investigating or defending the same) (collectively “Losses”) to which the Company and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters on the other from the offering of the Offered Shares; provided, however, that in no case shall any Underwriter (except as may be provided in any agreement among underwriters relating to the offering of the Offered Shares) be responsible for any amount in excess of the underwriting discount or commission applicable to the Offered Shares purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other in connection with the statements or omissions which resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company on the one hand or the Underwriters on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning of either the Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either the Act or
the Exchange Act, each officer of the Company who shall have signed the Registration Statement and the ADR Registration Statement and each director of the Company shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions of this paragraph (d).
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase and pay for any of the Offered Shares agreed to be purchased by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under this Underwriting Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions which the amount of Offered Shares set forth opposite their names in Schedule I hereto bears to the aggregate amount of Offered Shares set forth opposite the names of all the remaining Underwriters) the Offered Shares which the defaulting Underwriter or Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate amount of Offered Shares which the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate amount of Offered Shares set forth in Schedule I hereto, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Offered Shares and if such nondefaulting Underwriters do not purchase all the Offered Shares this Underwriting Agreement will terminate without liability to any nondefaulting Underwriter or the Company. In the event of a default by any Underwriter as set forth in this Section 9, the Closing Date shall be postponed for such period, not exceeding [five] Business Days, as the Representatives shall determine in order that any required changes in the Registration Statement, the ADR Registration Statement and the Prospectus or in any other documents or arrangements may be effected. Nothing contained in this Underwriting Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination.
(a) This Underwriting Agreement shall be subject to termination in the absolute discretion of the Representatives, by notice given to the Company prior to [·] [a.m./p.m.] on the Closing Date, if at any time prior to such time there shall have occurred any of the following: (i) since the time of execution of this Underwriting Agreement or the earlier respective dates as of which information is given in the Registration Statement, the ADR Registration Statement, the Preliminary Prospectus, the Prospectus and the Folleto (in each case, exclusive of any amendment or supplement thereto), there has been a material adverse change, or any development reasonably likely to result in a prospective material adverse change, in the business, properties, management, financial condition or results of operations of the Company and its subsidiaries, considered as a single business enterprise and whether or not arising in the ordinary course of business, the effect of which change or development is, in the judgment of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering or the delivery of the Offered Shares on the terms and in the manner contemplated in each Preliminary Prospectus, the Disclosure Package, the Prospectus or the Folleto; (ii) a general banking moratorium has been declared by European Union, Spanish, United Kingdom, U.S. federal or New York State authorities or there is a material disruption in commercial banking or securities settlement, payment or clearance services in the European Union, Spain, the United Kingdom, the United States or New York State; (iii) there has occurred a suspension or material
limitation in trading in the Company’s Class A Shares or Class B Shares or securities generally on, or minimum or maximum prices shall have been established in, any of the Spanish Stock Exchanges, the London Stock Exchange, the New York Stock Exchange or the Nasdaq Global Select Market; or (iv) there has occurred (A) any change or any development involving a prospective change in the national or international financial, political or economic conditions, any financial markets or any currency exchange rates or controls, (B) an outbreak or escalation of hostilities or acts of terrorism or a declaration of a national emergency or war, or (C) any other calamity or crisis, if the effect of any such event specified in this Section 10(a)(iv), individually or together with any other such event, in the judgment of the Representatives, is so material and adverse as to make it impractical or inadvisable to proceed with the offering or the delivery of the Offered Shares on the terms and in the manner contemplated in the Preliminary Prospectus, the Prospectus or the Nota sobre las Acciones (exclusive of any amendment or supplement thereto).
(b) The Representatives may terminate this Underwriting Agreement, by notice to the Company, in the following circumstances: (i) any judicial or administrative authority suspends or revokes the offer of the Offered Shares prior to the Closing Time, (ii) any of the conditions set forth in Section 6 hereof shall not have been met by the Closing Date or (iii) admission to listing of the Offered Shares on any of the Barcelona or the Madrid Stock Exchanges shall not have been obtained by 23:59 pm (CET) on [the [third] Madrid business day immediately after the Settlement Date].
(c) In the event of termination of this Underwriting Agreement pursuant to this Section 10, all offers of the Offered Shares will be automatically terminated and all offers to purchase and all purchase orders related to the offering shall be cancelled, and the Company shall have no obligation to deliver the Offered Shares and the Underwriters or final purchasers, as the case may be, shall have no obligation to subscribe or purchase for the Offered Shares.
In the event that this Underwriting Agreement is terminated pursuant to this Section 10 after the subscription and payment by the Pre-Funding Banks for the Pre-Funded Shares (as such term is defined in Appendix A hereto), the Company undertakes (i) to purchase from the Pre-Funding Banks, the Underwriters or the final purchasers, as the case may be, for their redemption, within [two] Madrid business days from the date of termination of this Underwriting Agreement, the maximum number of Offered Shares permitted by law to be repurchased by the Company as treasury stock at the Purchase Price plus interest accrued thereon at an annual rate of [·]% from the date of this Underwriting Agreement by way of a reverse special stock transaction to be settled three Madrid business days after on a delivery versus payment basis through the facilities and in accordance with the procedures of Iberclear for the settlement of transactions in the Spanish Stock Exchanges, and (ii) to cause the Board of Directors of the Company to convene within the same term indicated above an Extraordinary General Meeting to approve a share capital reduction resolution, which capital reduction shall be completed within three months from the date of termination of this Underwriting Agreement, by way of repurchase by the Company of the remaining Offered Shares at the Purchase Price plus interest accrued thereon at an annual rate of [·]% from the date of this Underwriting Agreement for their redemption with simultaneous allocation of the capital redemption reserve provided for in article 335 of the Spanish Capital Companies Act out of distributable reserves such that the creditors of the
Company do not to have the right to oppose to such share capital reduction, in order to return the Purchase Price for the Offered Shares to the Pre-Funding Banks, to the Underwriters or to the final subscribers of the Offered Shares, as the case may be. Subject to approval of the foregoing share capital reduction by the Extraordinary General Meeting of the Company, the Company will purchase from the Pre-Funding Banks, the Underwriters or the final subscribers, as the case may be, any such Offered Shares not previously repurchased by it pursuant to the provisions of this paragraph.
(d) In the event of the purchase of the Offered Shares, the share capital reduction of the Company referred to in Section 10(c) above or any combination of the foregoing, the Agent Bank will, on the settlement date of the relevant special stock transaction, (x) pay the entire or the corresponding portion of the amount standing to the credit of the Company Account; and (y) if the entire amount standing to the credit of the Company Account is less than the sum of the aggregate Purchase Price, as the case may be, plus interest at an annual rate of [·]% from the date of this Underwriting Agreement, the Company hereby irrevocably undertakes to pay an amount equal to the difference, to the Underwriters and/or final purchasers of shares, as the case may be, in the case of each of (x) and (y) pro rata to the number of Offered Shares acquired by them and against redelivery of such Offered Shares to the Company.
11. Representations and Indemnities to Survive. The respective agreements, representations, warranties, indemnities and other statements of the Company or its officers and of the Underwriters set forth in or made pursuant to this Underwriting Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter or the Company or any of the officers, directors, employees, agents or controlling persons referred to in Section 8 hereof, and will survive delivery of and payment for the Offered Shares. The provisions of Sections 7, 8, 11, 16, 17 and 18 hereof shall survive the termination or cancellation of this Underwriting Agreement.
12. Notices. All communications hereunder will be in writing and effective only on receipt, and, (i) if sent to the Representatives, will be mailed, delivered or telefaxed to [Citigroup Global Markets Limited, Citigroup Centre, Canada Square, Xxxxxx Xxxxx, Xxxxxx X00 0XX, Attention: Equity Syndicate, fax: + 00 00 0000 0000] and to [·] or (ii) if sent to the Company, will be mailed, delivered or telefaxed to Abengoa, S.A., General Xxxxxxxx Xxxxxx 00, 0xx xxxxx, 00000 Xxxxxx, Xxxxx, Attention: Deputy General Secretary, fax: +34 .
13. Successors. This Underwriting Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.
14. No Fiduciary Duty. The Company hereby acknowledges that (i) the purchase and sale of the Offered Shares pursuant to this Underwriting Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the Underwriters and any
affiliate through which they may be acting, on the other, (ii) the Underwriters are acting as principal and not as an agent or fiduciary of the Company and (iii) the Company’s engagement of the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company on related or other matters). The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto. The Company has consulted its own legal and financial advisors to the extent it deemed appropriate, and any review by the Representatives and the other Underwriters of the Company, the offering, the terms of the Offered Shares and other matters relating thereto will be performed solely for the benefit of the Representatives and Underwriters and shall not be on behalf of the Company or any other person.
15. Integration. This Underwriting Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.
16. Applicable Law. This Underwriting Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.
17. Waiver of Jury Trial. The Company hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Underwriting Agreement or the transactions contemplated hereby.
18. Jurisdiction. The Company agrees that any suit, action or proceeding against the Company brought by any Underwriter, the directors, officers, employees and agents of any Underwriter, or by any person who controls any Underwriter, arising out of or based upon this Underwriting Agreement or the transactions contemplated hereby may be instituted in any New York Court, and waives any objection which it may now or hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any suit, action or proceeding. The Company has appointed [name and address of designee] as its authorized agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Underwriting Agreement or the transactions contemplated herein which may be instituted in any New York Court, by any Underwriter, the directors, officers, employees and agents of any Underwriter, or by any person who controls any Underwriter, and expressly accepts the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. Notwithstanding the foregoing, any action arising out of or based upon this Underwriting Agreement may be instituted by any
Underwriter, the directors, officers, employees and agents of any Underwriter, or by any person who controls any Underwriter, in any court of competent jurisdiction in Spain.
The provisions of this Section 18 shall survive any termination of this Underwriting Agreement, in whole or in part.
19. Currency. Each reference in this Underwriting Agreement to U.S. Dollars (the “relevant currency”) is of the essence. To the fullest extent permitted by law, the obligations of the Company in respect of any amount due under this Underwriting Agreement will, notwithstanding any payment in any other currency (whether pursuant to a judgment or otherwise), be discharged only to the extent of the amount in the relevant currency that the party entitled to receive such payment may, in accordance with its normal procedures, purchase with the sum paid in such other currency (after any premium and costs of exchange) on the Business Day immediately following the day on which such party receives such payment. If the amount in the relevant currency that may be so purchased for any reason falls short of the amount originally due, the Company making such payment will pay such additional amounts, in the relevant currency, as may be necessary to compensate for the shortfall. Any obligation of any of the Company not discharged by such payment will, to the fullest extent permitted by applicable law, be due as a separate and independent obligation and, until discharged as provided herein, will continue in full force and effect.
20. Waiver of Immunity. To the extent that the Company has or hereafter may acquire any immunity (sovereign or otherwise) from any legal action, suit or proceeding, from jurisdiction of any court or from set-off or any legal process (whether service or notice, attachment in aid or otherwise) with respect to itself or any of its property, the Company hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its obligations under this Underwriting Agreement.
21. Counterparts. This Underwriting Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement.
22. Headings. The section headings used in this Underwriting Agreement are for convenience only and shall not affect the construction hereof.
23. Definitions. The terms which follow, when used in this Underwriting Agreement, shall have the meanings indicated.
“Act” shall mean the United States Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder.
“ADR Registration Statement” shall mean the registration statement (file number 333-[·]) of the Company on Form F-6, including all exhibits thereto, each as amended at the time such part of the registration statement became effective.
“Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated by law to close in New York City.
“Class A Shares” shall mean the Class A shares, €1.00 nominal value, of the Company, which are listed on the Madrid and Barcelona Stock Exchanges and traded through the SIB of the Spanish Stock Exchanges under the symbol “ABG.”
“Closing Time” shall mean the time of the special stock transaction (operación bursátil especial) that takes place on the Closing Date.
“CNMV” shall mean the Spanish Securities Market Commission (Comisión Nacional del Xxxxxxx de Valores).
“Commission” shall mean the United States Securities and Exchange Commission.
“Deposit Agreement” shall mean the Deposit Agreement, dated as of [·], 2013, to be entered into among the Company, the Depositary and all holders from time to time of the ADSs.
“Depositary” shall mean Citibank, N.A. as depositary under the Deposit Agreement.
“Disclosure Package” shall mean (i) the Preliminary Prospectus that is generally distributed to investors and used to offer the Securities, (ii) the Issuer Free Writing Prospectuses, if any, identified in Schedule II hereto, and (iii) any other Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package.
“Double Tax Treaty” shall mean a treaty entered into between two contracting nations that provides for the reduction or elimination of double taxation by the contracting nations on the same item(s) of income.
“Effective Date” shall mean each date and time that the Registration Statement and the ADR Registration Statement, any post-effective amendment or amendments thereto and any Rule 462(b) Registration Statement became or become effective.
“Exchange Act” shall mean the United States Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder.
“Execution Time” shall mean the date and time that this Underwriting Agreement is executed and delivered by the parties hereto.
“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.
“IFRS” shall mean International Financial Reporting Standards.
“IFRS as issued by the IASB” shall mean IFRS as issued by the International Accounting Standards Board.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as defined in Rule 433.
“Madrid business day” shall mean any day (other than a Saturday or a Sunday) that is neither a legal holiday nor a day on which banking institutions are authorized or required by law or regulation to close in Madrid, Spain.
“New York Courts” shall mean the U.S. Federal or State courts located in the State of New York, County of New York.
“Offered Notes” shall mean the Subordinated Mandatory Convertible Notes due [2016] mandatorily convertible into Class B Shares and ADSs of the Company.
“Offered Shares” shall mean the Underwritten Shares and the Option Shares.
“Preliminary Prospectus” shall mean any preliminary prospectus referred to in Section 1(a) hereof and any preliminary prospectus included in the Registration Statement at the Effective Date that omits Rule 430A Information.
“Prospectus” shall mean the prospectus relating to the Securities that is first filed pursuant to Rule 424(b) after the Execution Time.
“Registration Statement” shall mean the registration statement (file number 333-[·]) of the Company on Form F-1, including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430A, as amended at the Execution Time and, in the event any post-effective amendment thereto or any Rule 462(b) Registration Statement becomes effective prior to the Closing Date, shall also mean such registration statement as so amended or such Rule 462(b) Registration Statement, as the case may be.
“Representatives” shall mean the addressees of this Underwriting Agreement.
“Rule 158,” “Rule 163,” “Rule 164,” “Rule 172,” “Rule 405,” “Rule 415,” “Rule 424,” “Rule 430A,” “Rule 433” and “Rule 462” refer to such rules under the Act.
“Rule 430A Information” shall mean information with respect to the Securities and the offering thereof permitted to be omitted from the Registration Statement when it becomes effective pursuant to Rule 430A.
“Rule 462(b) Registration Statement” shall mean a registration statement and any amendments thereto filed pursuant to Rule 462(b) relating to the offering covered by the registration statement referred to in Section 1(a) hereof.
“Securities” shall mean the Offered Shares (or the ADSs representing such securities) and the Offered Notes.
“Settlement Date” shall mean the [third Madrid business day] after the Closing Date.
“SIB” shall mean the Automated Quotation System of the Spanish Stock Exchanges (Sistema de Interconexión Bursátil).
“Spanish Act” shall mean Act 24/1988, dated July 28, on the Securities Markets (Ley 24/1988, de 00 xx xxxxx, xxx Xxxxxxx xx Xxxxxxx).
“Spanish Capital Companies Act” shall mean the consolidated text of the Capital Companies Act, approved by Royal Legislative Decree 1/2010, of July 2 (texto refundido de xx Xxx de Sociedades de Capital, aprobado por el Real Decreto Legislativo 1/2010, de 2 de xxxxx).
“Spanish Stock Exchanges” shall mean each of the Madrid, Bilbao, Barcelona and Valencia Stock Exchanges.
“Stock Loan Agreement” shall mean the stock loan agreement entered into by Inversión Corporativa I.C. S.A. and [·] in connection with the offering of the Offered Shares.
“Underlying Shares” shall mean the Offered Shares that will be represented by ADSs.
“Underwriters” shall mean the several underwriters named in Schedule I to the Underwriting Agreement.
“Underwriting Agreement” shall mean this Underwriting Agreement relating to the sale of the Offered Shares by the Company to the Underwriters.
If the foregoing is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company and the several Underwriters.
|
|
Very truly yours, | |
|
|
| |
|
|
ABENGOA, S.A. | |
|
|
| |
|
|
By: |
|
|
|
|
Name: |
|
|
|
Title: |
|
The foregoing Agreement is hereby confirmed and accepted as of the date first above written. |
|
|
|
|
|
|
|
|
|
|
|
Citigroup Global Markets Limited |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
For itself and the other several Underwriters named in Schedule I to the foregoing Agreement |
|
|
|
|
|
|
|
|
|
|
|
[·] |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
|
|
|
|
For itself and the other several Underwriters named in Schedule I to the foregoing Agreement. |
|
|
SCHEDULE I
|
Underwriters |
|
Number of |
|
Percentage of |
|
|
|
|
|
|
|
|
|
Citigroup Global Markets Limited |
|
|
|
|
|
|
[·] |
|
|
|
|
|
|
[·] |
|
|
|
|
|
|
Total |
|
|
|
|
|
SCHEDULE II
Schedule of Free Writing Prospectuses included in the Disclosure Package
SCHEDULE III
|
Abeinsa Infraestructuras Medio Ambiente, S.A. |
|
|
|
Abeinsa, Ingeniería y Construcción Industrial, S.A. |
|
|
|
Abencor Suministros, S.A. |
|
|
|
Abener Energía, S.A. |
|
|
|
Abengoa Bioenergía, S.A. |
|
|
|
Abengoa Bioenergy Company, LLC |
|
|
|
Abengoa México, S.A. de C.V. |
|
|
|
Abentel Telecomunicaciones, S.A. |
|
|
|
ASA Investment Brasil Ltda. |
|
|
|
Befesa Medio Ambiente, S.A. |
|
|
|
Befesa Desulfuración, S.A. |
|
|
|
Ecoagrícola, S.A. |
|
|
|
Instalaciones Inabensa, S.A. |
|
|
|
Negocios Industriales y Comerciales, S.A. |
|
|
|
Bioetanol Xxxxxxx, X.X. |
|
|
|
Abengoa Bioenergy New Technologies, LLC. |
|
|
|
Abengoa Bioenergy of Nebraska, LLC |
|
|
|
Teyma Gestión de Contratos de Construcción e Ingeniería, S.A. |
|
|
|
Inabensa Rio Ltda. |
|
|
|
Teyma Internacional, S.A. |
|
|
|
Nicsamex, S.A. de C.V. |
|
|
|
Abentey Gerenciamento de Projetos de Engenharia e Construções Ltda. |
|
|
|
Abengoa Bioenergy Trading Europe B.V. |
|
|
|
Abengoa Concessões Brasil Holding S.A. |
|
|
|
Abengoa Solar España, S.A. |
|
Construcciones Metálicas Mexicanas Comemsa, S.A. de C.V. |
|
|
|
Europea de Construcciones Metálicas, S.A. |
|
|
|
Teyma USA & Abener Engineering and Construction Services General Partnership |
|
|
|
Siema Technologies |
|
|
|
Siema |
|
|
|
Abengoa Solar New Technologies S.A. |
|
|
|
Abengoa Water |
|
|
|
Abentey Mojave General Partnership |
|
|
|
Abentey Hugoton General Partnership |
|
|
|
Centro Morelos 264 S.A. de C.V. |
|
|
|
Abengoa Chile, S.A. |
|
[Form of Lock-Up Agreement] |
|
EXHIBIT A |
[Letterhead of officer, director or major stockholder of
Abengoa, S.A.]
Abengoa, S.A.
Public Offering of Class B Shares
[·], 2013
Citigroup Global Markets Limited
Citigroup Centre
Canada Square
Xxxxxx Xxxxx, Xxxxxx X00 0XX
[·]
As Representatives of the several Underwriters
Ladies and Gentlemen:
This letter is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”), between Abengoa, S.A., a Spanish corporation (the “Company”), and you as Representatives of the Underwriters named therein, relating to an underwritten public offering of Class B Shares, €0.01 par value per share (the “Class B Shares”), of the Company including, in the form of shares or American Depositary Shares (“ADSs”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
In order to induce you and the other Underwriters to enter into the Underwriting Agreement, the undersigned will not, without the prior written consent of the Representatives, offer, sell, contract to sell, pledge, or otherwise dispose of, (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company or any affiliate of the Company or any person in privity with the Company or any affiliate of the Company) directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, any Class A Shares, Class B Shares or ADSs or any securities convertible into, or exercisable, or exchangeable for, Class A Shares, Class B Shares or ADSs; or publicly announce an intention to effect any such transaction, from the date of the Underwriting Agreement to 180 days following the date of commencement of trading of the ADSs on the Nasdaq Global Select Market (such period, the “Restricted Period”), other than (A) transfers of Class A Shares, Class B Shares or ADSs or any securities
convertible into, or exercisable, or exchangeable for, Class A Shares, Class B Shares or ADSs as a bona fide gift or gifts, including as a result of the operation of law or estate or intestate succession, (B) if the undersigned is a natural person, to (i) a member of the immediate family of the undersigned (for purposes of this letter, “immediate family” shall mean any relationship by blood, marriage, or adoption, not more remote than first cousin), (ii) any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned or (iii) a corporation, partnership, limited liability company or other entity of which the undersigned and the immediate family of the undersigned are the direct or indirect legal and beneficial owners of all the outstanding equity securities or similar interests of such corporation, partnership, limited liability company or other entity; (C) if the undersigned is a corporation, partnership, limited liability company or other entity, to (i) any trust or other entity for the direct or indirect benefit of the undersigned or any affiliate, wholly-owned subsidiary, limited partner, member or stockholder of the undersigned or (ii) a corporation, partnership, limited liability company or other entity of which the undersigned and any affiliate, wholly-owned subsidiary, limited partner, member or stockholder of the undersigned are the direct or indirect legal and beneficial owners of all the outstanding equity securities or similar interests of such corporation, partnership, limited liability company or other entity, (D) distributions of Class A Shares, Class B Shares or ADSs or any securities convertible into, or exercisable, or exchangeable for, Class A Shares, Class B Shares or ADSs to partners, members or shareholders of the undersigned, and (E) to the undersigned’s affiliates or to any investment fund or other entity controlled or managed by the undersigned; provided that in the case of any transfer or distribution pursuant to clause (A), (B), (C), (D) or (E), each donee or distributee shall execute and deliver to the Representatives a lock-up letter in the form of this letter.
Notwithstanding the foregoing, if (i) during the last 17 days of the Restricted Period, the Company issues an earnings release or material news or a material event relating to the Company occurs; or (ii) prior to the expiration of the Restricted Period, the Company announces that it will release earnings results during the 16-day period beginning on the last day of the Restricted Period, the restrictions described above shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event, unless the Representatives waive, in writing, such extension. The undersigned hereby acknowledges that the Company has agreed in the Underwriting Agreement to provide written notice of any event that would result in an extension of the Restricted Period and agrees that any such notice properly delivered will be deemed to have been given to, and received by, the undersigned.
If the undersigned is an officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any issuer-directed Class B Shares the undersigned may purchase in the offering.
In addition, the undersigned, [Inversión Corporativa I.C. S.A. / Finarpisa, S.A.], holder of [·] Class A shares and of [·] Class B shares, represents that it is aware that in the event that the Underwriting Agreement is terminated after the pre-funding by the Pre-Funding Banks of the Underwritten Shares as provided in Section 10 of the
Underwriting Agreement, the Company shall cause the Board of Directors of the Company to convene within two Madrid business days from termination of the Underwriting Agreement an Extraordinary General Meeting to approve a share capital reduction resolution by way of repurchase by the Company of the remaining Offered Shares at the Purchase Price plus interest thereon at an annual rate of [·]% from the date of the Underwriting Agreement for their redemption with simultaneous allocation of the capital redemption reserve provided for in article 335 of the Spanish Capital Companies Act out of distributable reserves such that the creditors of the Company would not have the right to oppose to such share capital reduction, in order to return the Purchase Price for the Offered Shares to the Pre-Funding Banks, to the Underwriters or to the final subscribers of the Offered Shares, as the case may be.
[Inversión Corporativa I.C. S.A. / Finarpisa, S.A.] further undertakes to: cause its representatives on the Board of Directors of the Company to (i) vote for of the resolution convening the Extraordinary General Meeting or, in case the Extraordinary Shareholders’ Meeting is not convened by the Board of Directors within two Madrid business days from the date of termination of the Underwriting Agreement, to request the Company to call such Extraordinary General Meeting in the two following Madrid business days; and (ii) attend the Extraordinary General Meeting and vote for a share capital reduction and the allocation of the capital redemption reserve and the return of funds as provided in the preceding paragraph.
If for any reason the Underwriting Agreement shall be terminated prior to the Closing Date (as defined in the Underwriting Agreement), the agreement set forth above shall likewise be terminated.
|
|
Yours very truly, |
|
|
|
|
|
|
|
|
[Signature of officer, director or major stockholder] |
|
|
|
|
|
|
|
|
[Name and address of officer, director or major stockholder] |
|
Acknowledged and accepted as of the date first above written. |
|
|
|
|
|
|
|
|
|
|
|
Citigroup Global Markets Limited |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
For itself and the other several Underwriters named in Schedule I to the foregoing Agreement |
|
|
|
|
|
|
|
|
|
|
|
[·] |
|
|
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Name: |
|
|
|
Title: |
|
|
|
|
|
|
|
For itself and the other several Underwriters named in Schedule I to the foregoing |
|
|
|
[Form of Press Release] |
|
EXHIBIT B |
Abengoa, S.A.
[Date]
Abengoa, S.A., (the “Company”) announced today that Citigroup Global Markets Limited and [·] as the Representatives of the Underwriters in the Company’s recent public sale of Class B shares of common stock [and Subordinated Mandatory Convertible Bonds due 2016], are [waiving] [releasing] a lock-up restriction with respect to shares of the Company’s common stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on [·], and the shares may be sold on or after such date.
This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.
APPENDIX A
This Appendix A shall be deemed to form an integrated part of the Underwriting Agreement to which it is attached. All terms capitalized and not otherwise defined in this Appendix A shall have the meanings set forth in the Underwriting Agreement to which this Appendix A is attached.
The Underwriters hereby authorize the Pre-Funding Banks to subscribe and pay for the Underwritten Shares and the Option Shares (if the option provided for in Section 2 (b) hereof shall have been exercised on the date of the Underwriting Agreement) (the “Pre-Funded Shares”) and enter into, as the case may be, one or more loans on the terms the Pre-Funding Banks deem appropriate (in their sole discretion) to finance such subscription. The Pre-Funding Banks shall use their commercially reasonable efforts to obtain the financing of the amounts pre-funded by them on the most favorable terms reasonably available to them. Without prejudice to the other obligations of the parties under this Underwriting Agreement, the Underwriters shall, as against the Pre-Funding Banks, assume any liabilities arising from such subscription of the Pre-Funded Shares and any such loans in their respective underwriting proportions.
The payment contemplated by the preceding paragraph and representing an amount equal to the aggregate Purchase Price for the Pre-Funded Shares (the “Subscription Funds”) will be deposited by the Pre-Funding Banks with Banco Santander, S.A. (the “Agent Bank”) in the following account (the “Company Account”):
Banco Santander, S.A.
IBAN Code: [ ]
Swift: [ ]
Accountholder: ABENGOA, S.A.
Upon subscription and payment for the Pre-Funded Shares, the Pre-Funding Banks, acting in their own name and on behalf of the other Underwriters, will be recorded temporarily as the owners of the Pre-Funded Shares, in the Company’s book entry registry held at Iberclear.
If an election has been made to have ADSs delivered and paid for hereunder in lieu of all or any portion of the Pre-Funded Shares, on the Closing Date, the Pre-Funding Banks, acting in their own name and on behalf of the other Underwriters, will transfer a portion of the Pre-Funded Shares corresponding to such ADSs to the Depositary in exchange for ADSs representing such Pre-Funded Shares.
On the Closing Date, the Pre-Funding Banks shall transfer the Pre-Funded Shares (other than Pre-Funded Shares deposited with the Depositary and underlying ADSs) to the final purchasers thereof or, failing which, to the Underwriters, by means of a special stock exchange transaction (operación bursátil especial) to be settled no later than the Settlement Date. Payment by the final purchasers or, as the case may be, the Underwriters, to the Pre-Funding Banks for the Pre-Funded Shares (other than Pre-Funded Shares deposited with the Depositary and underlying ADSs) shall be made in
euro at the Purchase Price in immediately available funds by no later than 12:30 p.m. Madrid time on the Settlement Date (the “Payment Time”), against delivery of the Pre-Funded Shares as provided below.
If an election has been made to acquire Pre-Funded Shares represented by ADSs, the Pre-Funding Banks shall, on the Closing Date, transfer such ADSs to the final purchasers thereof or, failing which, to the Underwriters, to be settled no later than 9:30 a.m., New York time, on the Settlement Date, or at such other time and date as the Pre-Funding Banks and the Company may agree upon in writing (the “Time of Delivery of ADSs”). Payment by the final purchasers or, as the case may be, the Underwriters, to the Pre-Funding Banks for such ADSs shall be made by no later than the Time of Delivery of ADSs by transfer in immediately available funds in U.S. dollars to a U.S. dollar denominated account of the Company held at the Agent Bank (the “Company Dollar Account”) that the Company shall have designated by notice to the Pre-Funding Banks given not less than 24 hours prior to the Time of Delivery of ADSs, against delivery of the ADSs as provided below. The Company and the Underwriters hereby agree that at or prior to the Time of Delivery of ADSs, the Company shall transfer from the Company Account an amount in euro equivalent to the payment made pursuant to the preceding sentence, at an exchange rate of €1.00 = US$• (the noon buying rate on the date hereof), to the account of the Pre-Funding Banks that the Pre-Funding Banks shall have designated by notice to the Company given not less than 24 hours prior to the Time of Delivery of ADSs.
The funds deposited in the Company Account and the Company Dollar Account will be blocked and the Company will not be able to withdraw, debit or in any manner dispose of such funds until each of the following has occurred: (i) the Offered Shares have been admitted to trading in the Madrid and Barcelona Stock Exchanges; (ii) the ADSs have been admitted to trading on the Nasdaq Global Select Market; (iii) settlement of the offering contemplated herein takes place on the Settlement Date and the Pre-Funding Banks have received payment (in reimbursement for the Subscription Funds) from or on behalf of the Underwriters or final purchasers, as the case may be, of the Pre-Funded Shares (other than in respect of the Pre-Funding Banks’ respective own underwriting commitments); (iv) the Company has transferred to the Underwriters an amount in euro equivalent to the amount in U.S. dollars deposited in the Company Dollar Account pursuant to and in accordance with the immediately preceding paragraph of this Appendix A; and (v) the Agent Bank has withdrawn or segregated, as the case may be, and retained such funds as provided for in the immediately following paragraph of this Appendix A.
On the Closing Date, the Agent Bank shall withdraw from, or segregate within, the Company Account sufficient funds (in the amount notified to it by the Representatives) to make payment on the Closing Date to the Pre-Funding Banks, for the account of the several Underwriters, of the aggregate commissions set forth in Section 2 of the Underwriting Agreement in connection with the Pre-Funded Shares. The Company confirms that it has given all necessary instructions and approvals for the Agent Bank to apply the funds as provided in this Appendix A.
Any income having accrued in the Company Account in respect of the Subscription Funds from the Pre-funding Time until the later of (i) the Payment Time, (ii) the Time of Delivery of ADSs and (iii) in the case of termination of this Underwriting Agreement, the settlement date of the reverse special stock transaction contemplated in Section 10(c) of the Underwriting Agreement, shall be payable to the Pre-Funding Banks. The Company shall reimburse the Pre-Funding Banks for any funding costs net of such income resulting from the transfer, deposit and maintenance of the Subscription Funds to or in the Company Account that the Pre-Funding Banks may incur until the later of (x) the Payment Time, (y) the Time of Delivery of ADSs and (z) in the case of termination of this Underwriting Agreement, the settlement date of the reverse special stock transaction contemplated in Section 10(c).
The Company undertakes irrevocably to carry out the following actions on the Closing Date:
(i) following the deposit by the Pre-Funding Banks of the Subscription Funds into the Company Account, instruct, and procure that, the Agent Bank issues a certificate confirming payment in respect of the Pre-Funded Shares for the purposes of notarizing the capital increase necessary for the issue of the Pre-Funded Shares; and
(ii) after receiving payment from the Pre-Funding Banks, take all steps necessary to register the capital increase and the issue of the Pre-Funded Shares subscribed by the Underwriters with the Commercial Registry on the Closing Date. After registration with the Commercial Registry of the capital increase relating to the Pre-Funded Shares, use its best efforts to deliver on the same day of registration, certified or notarized copies of the public deed for the capital increase relating to the Pre-Funded Shares to the CNMV, to the Sociedades Rectoras de las Bolsas and to Iberclear, and deliver to the CNMV and the Sociedades Rectoras applications to list the Offered Shares on the Madrid and Barcelona Stock Exchanges for trading on the SIB.
Unless otherwise agreed, all Pre-Funded Shares to be delivered on the Settlement Date shall be delivered to the final purchasers by book-entry transfer (transferencia contable de anotaciones en cuenta) to the account or accounts specified by the Underwriters at a participating entity in Iberclear in such respective portions as the Underwriters may designate not less than one full Madrid business day prior to the Closing Date. If an election has been made to acquire ADSs, the ADR certificates evidencing the Pre-Funded Shares shall be registered in such names and in such denominations as the Representatives may request not less than one full New York business day immediately preceding the Settlement Date.
It is understood and agreed by the parties hereto that no delivery of Pre-Funded Shares to be issued and subscribed or purchased under the Underwriting Agreement on the Closing Date or the Settlement Date, as the case may be, shall be effective until and unless payment therefor has been made pursuant to the Underwriting Agreement and the Company shall have furnished or caused to be furnished to the Pre-
Funding Banks on the Settlement Date evidence satisfactory to the Pre-Funding Banks of the appropriate book-entry allotments and issues.
